US3812854A - Ultrasonic nebulizer - Google Patents

Ultrasonic nebulizer Download PDF

Info

Publication number
US3812854A
US3812854A US00299194A US29919472A US3812854A US 3812854 A US3812854 A US 3812854A US 00299194 A US00299194 A US 00299194A US 29919472 A US29919472 A US 29919472A US 3812854 A US3812854 A US 3812854A
Authority
US
United States
Prior art keywords
liquid
horn
porous
liquid medicament
porous body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00299194A
Inventor
R Buckles
M Keller
A Michaels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US00299194A priority Critical patent/US3812854A/en
Application granted granted Critical
Publication of US3812854A publication Critical patent/US3812854A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05BSPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B17/00Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups
    • B05B17/04Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods
    • B05B17/06Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations
    • B05B17/0607Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers
    • B05B17/0623Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers coupled with a vibrating horn
    • B05B17/063Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers coupled with a vibrating horn having an internal channel for supplying the liquid or other fluent material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001Particle size control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/005Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0085Inhalators using ultrasonics
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05BSPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B17/00Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups
    • B05B17/04Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods
    • B05B17/06Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations
    • B05B17/0607Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers
    • B05B17/0623Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers coupled with a vibrating horn

Definitions

  • ABSTRACT A device for the ultrasonic nebulization of liquids. Nebulization takes place in a porous solid body the porosity of which determines the size of the liquid particles generated. The device is especially suitable for nebulizing liquid medicaments for inhalation therapy.
  • This invention relates to ultrasonic nebulizers. More particularly, it relates to a device for ultrasonically producing liquid aerosols having controlled particle size. In a preferred embodiment, the invention relates to an improved ultrasonic nebulizer for inhalation therapy.
  • a common form of ultrasonic nebulizer achieves atomization by the disintegration of the geyser which is produced in a body of liquid by contacting the liquid with a focused beam of ultrasonic compressed wave energy.
  • Devices of this type have been used, for example, in inhalation therapy (see U.S. Pat. No. 3,561,444 issued Feb. 9, l97l to Boucher or No. 3,387,607 issued June 1 1, 1968 to Gauthier et al.) and in sample atomization (see U.S. Pat. No. 3,325,976 issued June 20, 1967 to West).
  • micron particles are laid down in the mouth and larynx, 6 to 9 micron particles are preferentially.
  • micron particles are preferentially deposited in the bronchioli, 1 to 3 micron particles are deposited in the alveoli, while particles much smaller than about 1-micron are not retained in the respiratory system by Brownian collision with all walls; most of these particles are exhaled.
  • respiratory diseases affect only one-of the areas of the respiratory system: for example, pneumonia and emphysema affect the alveoli, bronchitis affects the bronchioli, asthma affects the bronchi or bronchioli, etc.
  • drugs used to treat these diseases for example, epinephrine, norepinephrine, prostaglandins, steroids, antibiotics, detergents and the like are often highly potent and/or systemically toxic, it would be of utmost advantage to minimize drug dosage by delivering the drug precisely to the affected area. More precise particle size control than possible heretofore would help minimize extraneous drug applications.
  • Another way to reduce drug dosage during inhalation therapy would be to deliver the drug as a precisely timed pulse. It has been found that the flow of gas in and out of the respiratory system has essentially plug flow characteristics with the first gas inspired eventually filling the most distant alveoli, the last gas inspired filling only the larynx, etc. Precise delivery of an accurately determined pulse of atomized drug at an accurately determined point during inspiration, thus would result in further control of the location of drug deposit.
  • Prior ultrasonic nebulizers are not suitable for accurate Both of these conventional types of nebulizing devices can effectively continuously produce large volumes of crude aerosol but both have three serious disadvantages when preceise nebulization is desired. First, they do not permit accurate control of the amount of liquid atomized; second, they also require relatively long times (often I to 10 seconds) after starting to generate a stable consistent aerosol, and finally, they fail to directly generate an aerosol having uniformly sized particles (so-called monodispersed aerosols).
  • the respiratory system comprises a series of decreasing diameter branched tubes, including the mouth, larynx, trachea, bronchi, bronchioli and alveoli. It is pulsed delivery. These devices often require at least several seconds of tuning to achieve a usable aerosol. When used in pulsed applications, conventional ultrasonic nebulizers rely upon interrupting the transmission of the aerosol by bulky ducts and poorly controllable valves rather than by controlling the aerosols generation.
  • a further object of this invention is to provide an ultrasonic nebulizer which will permit precise control of the amount of liquid nebulized.
  • a further object of this invention is to provide an ultrasonic nebulizer which will permit control of the size of liquid particles formed.
  • Another object of this invention is to provide a device for the production of aerosols which may be used with improved efficiency for inhalation therapy or other therapeutic purposes.
  • Yet another object of this invention is to provide an ultrasonic nebulizer for inhalation therapy which can be controlled to deliver a medicament-containing aerosol in the form of a pulse of particular particle size and amount of medicament; positioned at a particular point in the inspiration cycle.
  • a nebulizer which includes a porous body having a defined intercommunicating pore structure, an oscillator capable of vibrating the porous body at an ultrasonic frequency and a system for supplying liquid to be nebulized to the pores of the porous body.
  • FIG. 1 is an essentially diagrammatic cross-sectional view of an embodiment of the ultrasonic nebulizer of the invention
  • FIG. 2 is an essentially diagrammatic cross-sectional view of another configuration of a nebulizer of the invention.
  • FIG. 3 is a cross-sectional view of yet another configuration of the nebulizer of the invention.
  • an ultrasonic nebulizer l embodying the present invention has a porous solid body 11 having a defined fixed intercommunicating pore structure.
  • Solid body 11 is affixed to ultrasonic horn or antennuator 12 which is in turn attached to a suitable piezoelectric crystal or other electro-mechanical transducer 14.
  • Crystal 14 is connected via cable 16 to high frequency signal generator which produces an ultrasonic signal of adequate power to oscillate crystal 14.
  • the frequency generated by generator 15 is very suitably the resonant frequency of crystal 14 or a harmonic thereof.
  • Cable 16, generator 15, crystal l4 and horn 12 in combination cause porous body 11 to vibrate at an ultrasonic frequency.
  • Liquid to be nebulized is forced under pressure from liquid supply 17 through conduit 18 through concentric channel (or bore) 19 in horn 12 to the interconnected pores of porous body 11 which communicate with channel 19.
  • Conduit 18 is attached to horn 12 in a manner which does not interfere with the ultrasonic oscillation of horn l2 and porous body 11.
  • FIG. 1 the embodiment of the invention illustrated in FIG. 1 is much simplified to clearly set out the invention. Details, such as for example a housing for the nebulizer or the method of flexibly attaching crystal 14 to the hous ing or the exact method of fastening conduit 18 to channel 19, may be supplied by one skilled in the art without departing from the spirit of this invention. Likewise, minor modifications, such as the addition of a capability for cooling crystal 14, may be employed.
  • liquid to be nebulized is passed through conduit 18 and channel 19 to porous body 11.
  • the pores of body 11 are intercommunicating, so that liquid can be conducted through solid body 11.
  • the liquid from channel 19 moves to the outer surface of porous body 11 and there is nebulized by the ultrasonic vibration into an aerosol having a particle size distribution which is related to the diameters of the pores of body 11.
  • liquids are nebulized to aerosols using an ultrasonically vibrating porous body having a fixed pore structure.
  • Aerosol particle size is a function Particle diameter 2 X pore diameter
  • the aerosol particles which result are uniformly from about 18 to 22 microns in diameter.
  • an aerosol having particles from about 7 to 9 micron in diameter is formed. This particle size to pore diameter relationship appears to hold over the range of body external pore diameters of from about 0.5 micron to about 50 microns.
  • a body having pores of a variety of sizes When a body having pores of a variety of sizes is employed, a multi-sized aerosol is obtained. In the preferred embodiments of this invention, wherein aerosols for inhalation therapy are produced, it is most often preferred to have uniform particle sizes. Bodies having uniform pore diameters in the range of from 0.5 to 5 microns produce aerosols ideal for many inhalation applications. Most specifically, bodies having all or a major proportion of their pores in the range of from 0.5 to 1.5 microns produce aerosols excellentfor inhalation treatment of the alveoli, bodies having their pores in the range of from 1.5 to 3 microns produce aerosols well suited for treating the bronchioli, while 3 to 5 micron pore bodies produce aerosols most useful for treating the bronchi. As used herein, a body is defined to have a uniform pore diameter within a range when at least about percent of all its pores fall within the given range. Preferably at least about percent of all the pores fit within the specified range.
  • pores of the porous body must be joined into an intercommunicating network since when used in accord with this invention, liquid will be passed from one side of the porous body through to the other side.
  • the size of the outer pores of the porous body should be fixed.
  • the material of construction of the porous body is not critical so long as it provides a fixed pore size.
  • Porous ceramic oxides may be used as well as porous glasses and metal frits, compressed porous plastics, and certain filters (e.g., nucleopore). These materials are readily available, being used conventionally as filters and catalyst supports.
  • the porous body should be relatively thin, generally not more than about 1 or 2 cms thick, preferably from 0.01 to 1 cm thick. Undesirably large amounts of energy are required to force the liquid to be nebulized through thicker bodies.
  • the porous body may be comprised of several layers, for example an internal macroporous layer, which permits the facile passage of liquid, in combination with an outer layer or skin having the required pore size distribution.
  • an internal macroporous layer which permits the facile passage of liquid, in combination with an outer layer or skin having the required pore size distribution.
  • Such a material can be made by carefully annealing or firing the surface of a macroporous support or by bonding a thin sheet of microporous ceramic, for example 0.005 cm thick, to a sheet of macroporous ceramic, for example 1 cm thick.
  • the porous body must be vibrated ultrasonically to produce the desired aerosol. This may be carried out by connecting the body to an ultrasonic vibrator such as, for example, by affixing the body to a piezoelectric ceramic crystal. This connection is preferably made through an antennuator horn, which when correctly matched to the piezoelectric crystal frequency, effeciently transmits the ultrasonic oscillation of the piezoelectric crystal to the porous body and if sized correctly permits the ultrasonic energy to be multiplied and focused in the porous body where nebulization occurs.
  • the size and shape of the antennuator horn 12 is not critical. Ideally, it is sized taking into consideration its material and the velocity of ultrasonic waves therethrough to achieve a harmonic relationship at the frequency employed.
  • the porous body is attached or affixed to the antennuator horn by a method enabling a tight fit and firm attachment to be achieved.
  • the antennuator horn is attached to a piezoelectric ceramic crystal or transducer 14.
  • Piezoelectric crystals and their use as transducers are well known. They may be made of materials such as lead zirconate or titanate, and calcium zironate or titanate, with or without traces of salts, for example yttrium, lanthanum, strontium or cobalt. To permit good electrical contact, they generally are coated on two opposite faces with electrically conducting metallic layers.
  • a high frequency signal generator drives the piezoelectric crystal. This generator is capable of producing a signal having a frequency of from l5.00 kilohertz (Khz) to about 100.00 Khz.
  • the power output required depends upon the amount of liquid being nebulized per unit time and the area and porosity of the porous body. As a general rule, at least 20,000 dyne-cm are needed to nebulize 1 cc of liquid into less than 20 micron particles. Best results are obtained when the power output is from about 1 X to about 1 X 10 dyne-cm.
  • Liquid to be nebulized is supplied to the porous body through channel 19 in antennuator horn 12.
  • Channel 19 is illustrated as coaxial with horn 12. This is not critical. It is essential that channel 19 contact body 11 in a manner that the pores of body lll can communicate with channel 19 and that liquid passing through channel 19 can pass through the pores to the surface of body 11 and there be nebulized.
  • Liquid is fed to channel 19 under pressure via conduit 17 from liquid supply 16. It is required that the liquid be fed under pressure if a substantial feed rate is to be achieved.
  • the pressure employed will depend on the pore size of body 11, the viscosity of the liquid being fed, etc. Generally, pressure of from I to 20 psi are suitable and may be achieved by for example, moving the liquid with pumps, compressed gas cylinders and the like.
  • a great variety of liquids may be nebulized by an apparatus as illustrated in FIG. 1.
  • Water and aqueous solutions such as of drugs, herbicides, dilute paints and dyes and the like are suitable, as are non-aqueous liquids and solutions having viscosities not appreciably greater than about 500 centipoises.
  • Viscous liquids such as heavy oils, generally are not suitable for nebulization with the present apparatus as they tend to clog the porous body.
  • Light organic materials such as lower hydrocarbons, oxyhydrocarbons and liquid halohydrocarbons may be easily nebulized for a variety of uses such as for flame spectrographic analysis and similar scientific investigations.
  • Liquid medicaments, both neat and in aqueous and non-aqueous solutions which meet the above viscosity criteria are very suitably nebulized by the device of this invention.
  • Medicaments which may be administered to the respiratory tract by the present invention include conventional inhalation therapy substances such as bronchodilator decongestants, for example, epinephrine, isoproterenol, isoetharime and phenylephrine; moistening thinning and detergent solutions such as superinone; mucolytic agents such as acetylcystune and enzymes, for example pancreatic enzyme; and water or saline humidity.
  • bronchodilator decongestants for example, epinephrine, isoproterenol, isoetharime and phenylephrine
  • moistening thinning and detergent solutions such as superinone
  • mucolytic agents such as acetylcystune and enzymes, for example pancreatic enzyme
  • water or saline humidity for example, water or saline humidity.
  • FIG. 2 a diagrammatic illustration is given of an embodiment of the nebulizer of this invention adapted for use as an inhaler for inhalation therapy.
  • the principle components of this inhaler inhaler 2 are the same as those of the nebulizer of FIG. 1, including porous body 11, antennuator horn l2, piezoelectric crystal 14, signal generator 15, cable 16 and liquid supply system 17, here shown as a pressure canister; connected to channel 19 via conduit 18.
  • Inhaler 2 also has, in combination with the foregoing components, a mouthpiece 20 adapted at one end to fit the patients mouth and to admit air as well as medicament through its other end as illustrated, as well as means for automatically controlling the nebulizer during the respiration cycle.
  • This automatic control includes an inspiration responsive detector 21, positioned in the airstream of mouthpiece 20, which reacts to changes in the velocity or pressure of the airstream within mouthpiece 20 thus signalling the commencement of inspiration to control 24 via means 22.
  • Control 24 then opens valve 25 via line 26 and admits the desired amount of medicament from supply pressure canister 17, to line 18, channel 19 and porous body 11.
  • Control 24 also turns on, via line 27, high frequency generator 15 which activates piezoelectric crystal 14 which ultrasonically vibrates horn 12 and attached porous body 11 to nebulize precisely the amount of medicament desired.
  • Inhalation detector 21 and controller 24 may be set to deliver medicament throughout the inspiration cycle or in an especially advantageous mode of operation may be set to order a short burst (say from 0.1 to 1 second) of medication ata preset point during inspiration.
  • This point may be based on the length of time from the start of inspiration or more preferably may be based on the volume of gas inspired.
  • the volume may be simply derived by detecting and integrating the inspiration velocity.
  • the nebulizer of this invention can produce a stable cosistant aerosol of uniform particle size essentially instantaneously, for example, within about 2 milliseconds. Thus it is possible to precisely-insert a burst of aerosolized medicament at any desired point in the inspiration cycle and therefore achieve much improved control of inhalation medicament delivery.
  • the inhaler of FIG. 2 can be constructed suitable for stationary or portable use. Because of the excellent direct control of particle size and amount of medicament nebulized, possible with the present invention, bulky filters, classifiers and the like are not required. Also, the electrical power demands of the inhaler of FIG. 2 are modest. Thus it can be constructed, if desired, to be battery operated in a highly portable form.
  • Atomizer 3 suitable for generating bulk inhalation aerosols or for nebulizing liquid chemical samples for spectrographic or chromatographic analysis is shown.
  • Atomizer 3 is similar to the embodiments of FIGS. 1 and 2 and includes porous body 11, which is here illustrated, not to scale, as a two layer body having a thin (0.05 cm) outer layer having the pore geometry which will give the particle size distribution desired the thicker (0.5 cm) inner layer having a macroporous structure adapted for the facile passage of liquid to be nebulized.
  • Porous body 11 is attached to antennuator horn 12 by means of threaded compression collar 29.
  • Horn 12 is attached to piezoelectric crystal 14 which is driven by ultrasonic oscillations generated by high frequency generator 15 and transmitted via cable 16.
  • Liquid to be nebulized for example water, is supplied under pressure by liquid supply 17 and line 18 to channel 19 on horn 12.
  • Channel 19 is branched at its upper end where it contacts body 11. This facilitates the more ready passage and even distribution of liquid into body 11.
  • the atomizer is mounted in housing 30, which is essentially sealed except for carrier gas inlet 31 and outlet 32.
  • carrier gas which for inhalation uses is usually air or oxygen containing a blend of gasses and for sample atomization is usually a noninterfering gas such as helium or nitrogen, is passed into housing 30 in inlet 31.
  • a mixture of nebulized liquid and carrier gas is then withdrawn via outlet 32 and used as intended by means not shown.
  • EXAMPLE I An ultrasonic nebulizer, substantially as shown in FIG. I, is constructed.
  • porous body 11 As porous body 11 is employed a 0.1 cm thick, 0.5 cm diameter disc of porous ceramic (aluminum oxide), having a relatively uniform porosity (some pores are as large as l or 12 microns, some are as small as about 4 microns) and a mean pore diameter of 6 microns.
  • This body is glued on horn 12, care being taken to avoid blocking the pores of body 11.
  • Antennuato'r horn 12 is constructed from brass and has the following dimensions: length, 3.12 inches, large diameter 0.45 inches, small diameter 0.20 inches.
  • Channel 19 is coaxially bored in horn l2 and it has a diameter of 0.025 inches.
  • a 0.50 inch piezoelectric ceramic is used as crystal [4.
  • a Hewlett-Packard signal generator and McIntosh 2 l 00 Amplifier having a power output of 205 watts is employed as generator 15.
  • Channel 19 is connected to a Harvard infusion pump.
  • a 30.00 kilohertz oscillation of l8.2 watts power is applied to antennuator horn l2 and porous body 11.
  • Water is pumped to porous body 11 at 20 psi pressure. The water nebulizes and is emitted from body 1 1 as an aerosol having particle diameters of from about 8 to about 20 microns corresponding to two times the diameter of the pores of body 11.
  • Example 2 The experiment of Example I is repeated with one modification. As porous body 11 is employed a similarly sized disc of porous ceramic having a mean pore diameter of microns. The aerosol produced in this experiment has an average particle size of about microns.
  • Example 3 The experiment of Example 1 is repeated with one modification.
  • the antennuator horn having an internal bore and a porous ceramic tip is replaced with a solid horn having no ceramic tip.
  • Liquid is fed to the end of the horn via an external 0.040 inch diameter'tube and a Harvard Positive Displacement pump, operated at 10 psi.
  • An ultrasonic frequency varying from 25 KHz to KHz is applied, with energies of from X 10 400 X 10" dyne-cm. Throughout these ranges of frequencies and energies only randomly sized l0 70 micron particles of liquid are formed.
  • EXAMPLE 4 A series of experiments in accord with the experiment of Example 1 are conducted. In three experiments the liquid flow rate is varied from 0.0817 [Ll/SEC to 0.4l7 (Ll/Sec. The power requirement changes from 29 watts to 18 watts as the liquid feed is decreased. (all at 30 KHz). The particle size of the resulting aerosol remains constant averaging 15 microns.
  • EXAMPLE 5 a An inhaler substantially in accord with FIG. 2 is constructed. As liquid is employed a solution of medicament comprising epinephrine in distilled water. Controller 24 is set to order nebulization of medicament throughout the inspiration cycle. As porous body 11 is employed a glass frit having a uniform pore diameter of 5 to 6 microns. A patient inhales through mouthpiece 20. This flow of air is noted by detector 2]. Controller 24, responding to the signal of detector 21, then opens valve 25 and energizes high frequency generator 15 which in turn actuates crystal 14 which vibrates horn 12 and porous body 11. The medicament is nebulized into an aerosol having 10 to l2 micron particles which is inspired by the subject. These particles preferentially deposit on the throat and larynx of a patient employing the inhaler.
  • part (a) is repeated using a 3 to 5 micron pore size glass frit. An aerosol having 6 to 10 micron particles is formed. This aerosol deposits preferentially in an inhaling patients bronchi.
  • Controller 24 is set to deliver only a short pulse of aerosol positioned at the initial portion of the inspiration cycle. In this case, the particles of medicament tiavell to and are primarily deposited in the most distant a V60 1.
  • EXAMPLE 6 A sample of lower ketones is to be analyzed by flame photometric detector gas chromatograph.
  • An aerosolizer in accord with FIG. 3 is constructed using a bilayer ceramic porous body, the outer layer having an average 9 pore diameter of 2 microns, the inner having a 30 mircon average pore diameter.
  • the mixed ketones are fed to the porous body, a suitable ultrasonic frequency is applied and a suitable carrier gas is fed via inlet 31.
  • An aerosol of ketone is produced by the nebulizer and is carried therefrom by a carrier gas through the chromatograph to a flame photometeric detector where it is analyzed.
  • An ultrasonic nebulizer for atomizing a liquid medicament comprising in combination:
  • porous body comprises an internal macroporous layer which permits facile passage of said liquid medicament and an outer porous layer whose exterior surface defines said one end.
  • nebulizer adapted to atomize the liquid medicament for inhalation by a patient and including:
  • a mouthpiece for transferring the atomized liquid medicament from said one end of the porous body to the mouth of the patient, one end of which communicates with said one end of the porous body and the other end of which is adapted to be received within the mouth of the patient.
  • An ultrasonic nebulizer for atomizing a liquid according to claim 1 wherein the means for supplying liquid to the pores of the porous solid body comprises means for supplying liquid under pressure to a bore in the antennuator horn, which bore communicates with the pores of the porous solid body.
  • An ultrasonic nebulizer for atomizing a liquid medicament for inhalation by a patient comprising in combination, a cylindrical antennuator horn having a large diameter end and distal therefrom a small diameter end and a passageway extending from the small diameter end coaxially through the horn to an external opening; a porous solid body having external pores of diameter of from 0.5 microns to 5 microns affixed to the small diameter end of the antennuator horn, and having a defined intercommunicating pore structure in communication with the passageway; liquid supply means for supplying the liquid medicament to the external opening of the passageway; vibrating means for vibrating the cylindrical antennuator horn and afiixed porous solid body at a frequency of from about 15 Khz to about Khz; and a mouthpiece one end of which communicates with said external pores and the other end of which is adapted to be received within the mouth of the patient.
  • An ultrasonic nebulizer including an inspiration responsive detector positioned within the airstream in said mouthpiece and operatively interconnected with said liquid supply means and said vibrating means, said detector being adapted to activate the liquid supply means and vibrating means in response to physical changes it detects within said air stream.

Abstract

A device for the ultrasonic nebulization of liquids. Nebulization takes place in a porous solid body the porosity of which determines the size of the liquid particles generated. The device is especially suitable for nebulizing liquid medicaments for inhalation therapy.

Description

ilnited States Patent Michaels et a1.
[ May 28, 1974 Primary Examiner-Richard A. Gaudet Assistant Examiner-Lee S. Cohen Attorney, Agent, or Firm-Thomas E. Ciotti; Edward L. Mandell; Paul L. Sabatine [57] ABSTRACT A device for the ultrasonic nebulization of liquids. Nebulization takes place in a porous solid body the porosity of which determines the size of the liquid particles generated. The device is especially suitable for nebulizing liquid medicaments for inhalation therapy.
8 Claims, 3 Drawing Figures 1 1 ULTRASONIC NEBULIZER [76] lnventors: Alan S. Michaels, 97 Mt. Vernon,
Atherton; Richard G. Buckles, 491
Middle Ct., Menlo Park, both of Calif. 94025; Michael P. Keller, 2272 Latham St., Mountain View, Calif. 94040 [22] Filed: Oct. 20, 1972 [21] App]. No.: 299,194
[52] US. Cl 128/194, 128/D1G. 2, 239/102 [51] Int. Cl A6lm 15/00 [58] Field of Search 128/194, DIG. 2, 172, 173, 128/193, 145.8, 145.6; 259/D1G. 44; 239/102, 4, 338
[56] References Cited UNITED STATES PATENTS 2,658,169 11/1953 Barret 128/172 x 2 1&4
18 HIGH FREQUENCY G EN ERATOR RNTENIENNN RM I $812,854
/l4 [2 HIGH x FREQUENCY GENERATOR x LIQUID I N; IG.I F SUPPLY I? I LIQUID MOMMA l GENERATOR 16 I8 Y SUPPLY 1 ULTRASONM NEBULIZER BACKGROUND OF THE INVENTION 1. Field Of The Invention This invention relates to ultrasonic nebulizers. More particularly, it relates to a device for ultrasonically producing liquid aerosols having controlled particle size. In a preferred embodiment, the invention relates to an improved ultrasonic nebulizer for inhalation therapy.
2. The Prior Art The art is replete with processes which employ aerosols of liquids. Paints, biocides, personal and home care products, gas chromatography and spectroscopy samples, and inhalable drugs are representative of the many materials which are advantageously employed as aerosols. Most commonly, aerosols are generated by drawing the liquid into a high velocity stream of propellant gas. With the growing awareness of the health hazards posed by many of the known propellants, especially the Freon-type gases, other methods of generating aerosols are receiving increased attention.
It is known that aerosols can be generated ultrasonically. A common form of ultrasonic nebulizer achieves atomization by the disintegration of the geyser which is produced in a body of liquid by contacting the liquid with a focused beam of ultrasonic compressed wave energy. Devices of this type have been used, for example, in inhalation therapy (see U.S. Pat. No. 3,561,444 issued Feb. 9, l97l to Boucher or No. 3,387,607 issued June 1 1, 1968 to Gauthier et al.) and in sample atomization (see U.S. Pat. No. 3,325,976 issued June 20, 1967 to West). Another known type of ultrasonic nebulizer achieves atomization by dripping the liquid to be dispersed onto a continuously ultrasonically vibrating solid plate which breaks the liquid into a variety of particles. Such a device is shown in U.S. Pat. No. 3,291,122 issued Dec. 13, 1966 to Engstrom et al.
known that the point at which an aerosol particle deposits in the respiratory system is a function of particle size; micron particles are laid down in the mouth and larynx, 6 to 9 micron particles are preferentially.
deposited in the bronchi, 3 to 6 micron particles are preferentially deposited in the bronchioli, 1 to 3 micron particles are deposited in the alveoli, while particles much smaller than about 1-micron are not retained in the respiratory system by Brownian collision with all walls; most of these particles are exhaled.
Many respiratory diseases affect only one-of the areas of the respiratory system: for example, pneumonia and emphysema affect the alveoli, bronchitis affects the bronchioli, asthma affects the bronchi or bronchioli, etc. Since the drugs used to treat these diseases, for example, epinephrine, norepinephrine, prostaglandins, steroids, antibiotics, detergents and the like are often highly potent and/or systemically toxic, it would be of utmost advantage to minimize drug dosage by delivering the drug precisely to the affected area. More precise particle size control than possible heretofore would help minimize extraneous drug applications.
Another way to reduce drug dosage during inhalation therapy would be to deliver the drug as a precisely timed pulse. It has been found that the flow of gas in and out of the respiratory system has essentially plug flow characteristics with the first gas inspired eventually filling the most distant alveoli, the last gas inspired filling only the larynx, etc. Precise delivery of an accurately determined pulse of atomized drug at an accurately determined point during inspiration, thus would result in further control of the location of drug deposit.
Prior ultrasonic nebulizers are not suitable for accurate Both of these conventional types of nebulizing devices can effectively continuously produce large volumes of crude aerosol but both have three serious disadvantages when preceise nebulization is desired. First, they do not permit accurate control of the amount of liquid atomized; second, they also require relatively long times (often I to 10 seconds) after starting to generate a stable consistent aerosol, and finally, they fail to directly generate an aerosol having uniformly sized particles (so-called monodispersed aerosols).
This last failing is especially serious since it is often necessary or desirable to have a monodispersed aerosol. On a theoretical basis, it has been shown that continuous ultrasonic nebulizers should produce uniform particles related in diameter to the reciprocal of the ultrasonic frequency employed. In practice, however, prior ultrasonic atomizers have produced a variety of extraneous large particles which must be screened, settled or otherwise removed, albeit incompletely, as may be noted in U.S. Pat. No. 3,291,122 and Boucher et al. 26 Annals ofAllergy 591 at FIG. 4 (1968). This inability to control particle size has limited the usefulness of conventional ultrasonic nebulizers especially in inhalation treatment of the respiratory system where precise control of particle size is most advantageous and true monodispersed aerosols have been long desired.
The respiratory system comprises a series of decreasing diameter branched tubes, including the mouth, larynx, trachea, bronchi, bronchioli and alveoli. It is pulsed delivery. These devices often require at least several seconds of tuning to achieve a usable aerosol. When used in pulsed applications, conventional ultrasonic nebulizers rely upon interrupting the transmission of the aerosol by bulky ducts and poorly controllable valves rather than by controlling the aerosols generation.
OBJECTS OF THE INVENTION Accordingly, it is an object of the present invention to provide a new and improved nebulizer of the ultrasonic type.
A further object of this invention is to provide an ultrasonic nebulizer which will permit precise control of the amount of liquid nebulized.
A further object of this invention is to provide an ultrasonic nebulizer which will permit control of the size of liquid particles formed.
Another object of this invention is to provide a device for the production of aerosols which may be used with improved efficiency for inhalation therapy or other therapeutic purposes.
Yet another object of this invention is to provide an ultrasonic nebulizer for inhalation therapy which can be controlled to deliver a medicament-containing aerosol in the form of a pulse of particular particle size and amount of medicament; positioned at a particular point in the inspiration cycle.
STATEMENT OF THE INVENTION It has now been found that the foregoing objects, as well as other objects, advantages, and features which will become apparent from the detailed description to follow, are attained by a nebulizer which includes a porous body having a defined intercommunicating pore structure, an oscillator capable of vibrating the porous body at an ultrasonic frequency and a system for supplying liquid to be nebulized to the pores of the porous body.
BRIEF DESCRIPTION OF THE DRAWINGS In the drawings,,..wherein like reference numerals designate like parts:
FIG. 1 is an essentially diagrammatic cross-sectional view of an embodiment of the ultrasonic nebulizer of the invention;
FIG. 2 is an essentially diagrammatic cross-sectional view of another configuration of a nebulizer of the invention, and
FIG. 3 is a cross-sectional view of yet another configuration of the nebulizer of the invention.
DETAILED DESCRIPTION OF THE INVENTION As illustrated in FIG. 1, an ultrasonic nebulizer l embodying the present invention has a porous solid body 11 having a defined fixed intercommunicating pore structure. Solid body 11 is affixed to ultrasonic horn or antennuator 12 which is in turn attached to a suitable piezoelectric crystal or other electro-mechanical transducer 14. Crystal 14 is connected via cable 16 to high frequency signal generator which produces an ultrasonic signal of adequate power to oscillate crystal 14. The frequency generated by generator 15 is very suitably the resonant frequency of crystal 14 or a harmonic thereof. Cable 16, generator 15, crystal l4 and horn 12 in combination cause porous body 11 to vibrate at an ultrasonic frequency. Liquid to be nebulized is forced under pressure from liquid supply 17 through conduit 18 through concentric channel (or bore) 19 in horn 12 to the interconnected pores of porous body 11 which communicate with channel 19. Conduit 18 is attached to horn 12 in a manner which does not interfere with the ultrasonic oscillation of horn l2 and porous body 11. As will be appreciated by those skilled in the art, the embodiment of the invention illustrated in FIG. 1 is much simplified to clearly set out the invention. Details, such as for example a housing for the nebulizer or the method of flexibly attaching crystal 14 to the hous ing or the exact method of fastening conduit 18 to channel 19, may be supplied by one skilled in the art without departing from the spirit of this invention. Likewise, minor modifications, such as the addition of a capability for cooling crystal 14, may be employed.
In operation, liquid to be nebulized is passed through conduit 18 and channel 19 to porous body 11. The pores of body 11 are intercommunicating, so that liquid can be conducted through solid body 11. Thus the liquid from channel 19 moves to the outer surface of porous body 11 and there is nebulized by the ultrasonic vibration into an aerosol having a particle size distribution which is related to the diameters of the pores of body 11.
In accordance with the present invention, liquids are nebulized to aerosols using an ultrasonically vibrating porous body having a fixed pore structure. Unlike prior ultrasonic nebulizers wherein the size of the particles in the aerosol was determined by the frequency of the ultrasonic vibration, the particle sizes achieved with the instant nebulizers are related to the internal geometry of this porous body. Aerosol particle size is a function Particle diameter 2 X pore diameter For example, when a porous body having uniform 10 micron pores is used in the present invention, the aerosol particles which result are uniformly from about 18 to 22 microns in diameter. When a porous body having uniform 4 mircon diameter external surface pores is substituted an aerosol having particles from about 7 to 9 micron in diameter is formed. This particle size to pore diameter relationship appears to hold over the range of body external pore diameters of from about 0.5 micron to about 50 microns.
When a body having pores of a variety of sizes is employed, a multi-sized aerosol is obtained. In the preferred embodiments of this invention, wherein aerosols for inhalation therapy are produced, it is most often preferred to have uniform particle sizes. Bodies having uniform pore diameters in the range of from 0.5 to 5 microns produce aerosols ideal for many inhalation applications. Most specifically, bodies having all or a major proportion of their pores in the range of from 0.5 to 1.5 microns produce aerosols excellentfor inhalation treatment of the alveoli, bodies having their pores in the range of from 1.5 to 3 microns produce aerosols well suited for treating the bronchioli, while 3 to 5 micron pore bodies produce aerosols most useful for treating the bronchi. As used herein, a body is defined to have a uniform pore diameter within a range when at least about percent of all its pores fall within the given range. Preferably at least about percent of all the pores fit within the specified range.
The pores of the porous body must be joined into an intercommunicating network since when used in accord with this invention, liquid will be passed from one side of the porous body through to the other side.
To achieve reproducible results, the size of the outer pores of the porous body should be fixed. The material of construction of the porous body is not critical so long as it provides a fixed pore size. Porous ceramic oxides may be used as well as porous glasses and metal frits, compressed porous plastics, and certain filters (e.g., nucleopore). These materials are readily available, being used conventionally as filters and catalyst supports.
The porous body should be relatively thin, generally not more than about 1 or 2 cms thick, preferably from 0.01 to 1 cm thick. Undesirably large amounts of energy are required to force the liquid to be nebulized through thicker bodies.
The porous body may be comprised of several layers, for example an internal macroporous layer, which permits the facile passage of liquid, in combination with an outer layer or skin having the required pore size distribution. Such a material can be made by carefully annealing or firing the surface of a macroporous support or by bonding a thin sheet of microporous ceramic, for example 0.005 cm thick, to a sheet of macroporous ceramic, for example 1 cm thick.
The porous body must be vibrated ultrasonically to produce the desired aerosol. This may be carried out by connecting the body to an ultrasonic vibrator such as, for example, by affixing the body to a piezoelectric ceramic crystal. This connection is preferably made through an antennuator horn, which when correctly matched to the piezoelectric crystal frequency, effeciently transmits the ultrasonic oscillation of the piezoelectric crystal to the porous body and if sized correctly permits the ultrasonic energy to be multiplied and focused in the porous body where nebulization occurs. The size and shape of the antennuator horn 12 is not critical. Ideally, it is sized taking into consideration its material and the velocity of ultrasonic waves therethrough to achieve a harmonic relationship at the frequency employed.
The porous body is attached or affixed to the antennuator horn by a method enabling a tight fit and firm attachment to be achieved. The exact method of affixing the porous body to the antennuator horn, while not critical, must be chosen with care. A tight fit must be achieved. Glueing or soldering can be used so long as the pores of the porous body are not blocked or appreciably obstructed. Clamping or threading the porous body to the antennuator horn are acceptable means of attachment.
The antennuator horn is attached to a piezoelectric ceramic crystal or transducer 14. Piezoelectric crystals and their use as transducers are well known. They may be made of materials such as lead zirconate or titanate, and calcium zironate or titanate, with or without traces of salts, for example yttrium, lanthanum, strontium or cobalt. To permit good electrical contact, they generally are coated on two opposite faces with electrically conducting metallic layers. A high frequency signal generator drives the piezoelectric crystal. This generator is capable of producing a signal having a frequency of from l5.00 kilohertz (Khz) to about 100.00 Khz. The power output required depends upon the amount of liquid being nebulized per unit time and the area and porosity of the porous body. As a general rule, at least 20,000 dyne-cm are needed to nebulize 1 cc of liquid into less than 20 micron particles. Best results are obtained when the power output is from about 1 X to about 1 X 10 dyne-cm.
Liquid to be nebulized is supplied to the porous body through channel 19 in antennuator horn 12. Channel 19 is illustrated as coaxial with horn 12. This is not critical. It is essential that channel 19 contact body 11 in a manner that the pores of body lll can communicate with channel 19 and that liquid passing through channel 19 can pass through the pores to the surface of body 11 and there be nebulized. Liquid is fed to channel 19 under pressure via conduit 17 from liquid supply 16. It is required that the liquid be fed under pressure if a substantial feed rate is to be achieved. The pressure employed will depend on the pore size of body 11, the viscosity of the liquid being fed, etc. Generally, pressure of from I to 20 psi are suitable and may be achieved by for example, moving the liquid with pumps, compressed gas cylinders and the like.
A great variety of liquids may be nebulized by an apparatus as illustrated in FIG. 1. Water and aqueous solutions, such as of drugs, herbicides, dilute paints and dyes and the like are suitable, as are non-aqueous liquids and solutions having viscosities not appreciably greater than about 500 centipoises. Viscous liquids, such as heavy oils, generally are not suitable for nebulization with the present apparatus as they tend to clog the porous body. Light organic materials such as lower hydrocarbons, oxyhydrocarbons and liquid halohydrocarbons may be easily nebulized for a variety of uses such as for flame spectrographic analysis and similar scientific investigations. Liquid medicaments, both neat and in aqueous and non-aqueous solutions which meet the above viscosity criteria are very suitably nebulized by the device of this invention.
Medicaments which may be administered to the respiratory tract by the present invention include conventional inhalation therapy substances such as bronchodilator decongestants, for example, epinephrine, isoproterenol, isoetharime and phenylephrine; moistening thinning and detergent solutions such as superinone; mucolytic agents such as acetylcystune and enzymes, for example pancreatic enzyme; and water or saline humidity.
Turning now to FIG. 2, a diagrammatic illustration is given of an embodiment of the nebulizer of this invention adapted for use as an inhaler for inhalation therapy. The principle components of this inhaler inhaler 2) are the same as those of the nebulizer of FIG. 1, including porous body 11, antennuator horn l2, piezoelectric crystal 14, signal generator 15, cable 16 and liquid supply system 17, here shown as a pressure canister; connected to channel 19 via conduit 18. Inhaler 2 also has, in combination with the foregoing components, a mouthpiece 20 adapted at one end to fit the patients mouth and to admit air as well as medicament through its other end as illustrated, as well as means for automatically controlling the nebulizer during the respiration cycle. This automatic control includes an inspiration responsive detector 21, positioned in the airstream of mouthpiece 20, which reacts to changes in the velocity or pressure of the airstream within mouthpiece 20 thus signalling the commencement of inspiration to control 24 via means 22. Control 24 then opens valve 25 via line 26 and admits the desired amount of medicament from supply pressure canister 17, to line 18, channel 19 and porous body 11. Control 24 also turns on, via line 27, high frequency generator 15 which activates piezoelectric crystal 14 which ultrasonically vibrates horn 12 and attached porous body 11 to nebulize precisely the amount of medicament desired. Inhalation detector 21 and controller 24 may be set to deliver medicament throughout the inspiration cycle or in an especially advantageous mode of operation may be set to order a short burst (say from 0.1 to 1 second) of medication ata preset point during inspiration. This point may be based on the length of time from the start of inspiration or more preferably may be based on the volume of gas inspired. The volume may be simply derived by detecting and integrating the inspiration velocity. The nebulizer of this invention can produce a stable cosistant aerosol of uniform particle size essentially instantaneously, for example, within about 2 milliseconds. Thus it is possible to precisely-insert a burst of aerosolized medicament at any desired point in the inspiration cycle and therefore achieve much improved control of inhalation medicament delivery.
Although these constructional details are not illustrated, the inhaler of FIG. 2 can be constructed suitable for stationary or portable use. Because of the excellent direct control of particle size and amount of medicament nebulized, possible with the present invention, bulky filters, classifiers and the like are not required. Also, the electrical power demands of the inhaler of FIG. 2 are modest. Thus it can be constructed, if desired, to be battery operated in a highly portable form.
Turning now to FIG. 3, an embodiment of the invention, atomizer 3, suitable for generating bulk inhalation aerosols or for nebulizing liquid chemical samples for spectrographic or chromatographic analysis is shown. Atomizer 3 is similar to the embodiments of FIGS. 1 and 2 and includes porous body 11, which is here illustrated, not to scale, as a two layer body having a thin (0.05 cm) outer layer having the pore geometry which will give the particle size distribution desired the thicker (0.5 cm) inner layer having a macroporous structure adapted for the facile passage of liquid to be nebulized. Porous body 11 is attached to antennuator horn 12 by means of threaded compression collar 29. Horn 12 is attached to piezoelectric crystal 14 which is driven by ultrasonic oscillations generated by high frequency generator 15 and transmitted via cable 16. Liquid to be nebulized, for example water, is supplied under pressure by liquid supply 17 and line 18 to channel 19 on horn 12. Channel 19 is branched at its upper end where it contacts body 11. This facilitates the more ready passage and even distribution of liquid into body 11. The atomizer is mounted in housing 30, which is essentially sealed except for carrier gas inlet 31 and outlet 32. In operation, carrier gas, which for inhalation uses is usually air or oxygen containing a blend of gasses and for sample atomization is usually a noninterfering gas such as helium or nitrogen, is passed into housing 30 in inlet 31. A mixture of nebulized liquid and carrier gas is then withdrawn via outlet 32 and used as intended by means not shown.
- The following examples are merely illustrative of the present invention and are not to be considered as limiting the scope of the invention in any way.
EXAMPLE I An ultrasonic nebulizer, substantially as shown in FIG. I, is constructed. As porous body 11 is employed a 0.1 cm thick, 0.5 cm diameter disc of porous ceramic (aluminum oxide), having a relatively uniform porosity (some pores are as large as l or 12 microns, some are as small as about 4 microns) and a mean pore diameter of 6 microns. This body is glued on horn 12, care being taken to avoid blocking the pores of body 11. Antennuato'r horn 12 is constructed from brass and has the following dimensions: length, 3.12 inches, large diameter 0.45 inches, small diameter 0.20 inches. Channel 19 is coaxially bored in horn l2 and it has a diameter of 0.025 inches. A 0.50 inch piezoelectric ceramic is used as crystal [4. A Hewlett-Packard signal generator and McIntosh 2 l 00 Amplifier having a power output of 205 watts is employed as generator 15. Channel 19 is connected to a Harvard infusion pump. In operation, a 30.00 kilohertz oscillation of l8.2 watts power is applied to antennuator horn l2 and porous body 11. Water is pumped to porous body 11 at 20 psi pressure. The water nebulizes and is emitted from body 1 1 as an aerosol having particle diameters of from about 8 to about 20 microns corresponding to two times the diameter of the pores of body 11.
EXAMPLE 2 The experiment of Example I is repeated with one modification. As porous body 11 is employed a similarly sized disc of porous ceramic having a mean pore diameter of microns. The aerosol produced in this experiment has an average particle size of about microns.
EXAMPLE 3 The experiment of Example 1 is repeated with one modification. The antennuator horn having an internal bore and a porous ceramic tip is replaced with a solid horn having no ceramic tip. Liquid is fed to the end of the horn via an external 0.040 inch diameter'tube and a Harvard Positive Displacement pump, operated at 10 psi. An ultrasonic frequency varying from 25 KHz to KHz is applied, with energies of from X 10 400 X 10" dyne-cm. Throughout these ranges of frequencies and energies only randomly sized l0 70 micron particles of liquid are formed.
EXAMPLE 4 A series of experiments in accord with the experiment of Example 1 are conducted. In three experiments the liquid flow rate is varied from 0.0817 [Ll/SEC to 0.4l7 (Ll/Sec. The power requirement changes from 29 watts to 18 watts as the liquid feed is decreased. (all at 30 KHz). The particle size of the resulting aerosol remains constant averaging 15 microns.
In three additional experiments the glued porous body is replaced by a body of the same material attached by a threaded brass collar. Because of the resulting change in horn mass a new frequency (28 KHz) is found to be optimum. The aerosol particle sizes are the same as in the first three experiments. The power requirements at similar flow rates are reduced to form 18 to ll watts.
EXAMPLE 5 a. An inhaler substantially in accord with FIG. 2 is constructed. As liquid is employed a solution of medicament comprising epinephrine in distilled water. Controller 24 is set to order nebulization of medicament throughout the inspiration cycle. As porous body 11 is employed a glass frit having a uniform pore diameter of 5 to 6 microns. A patient inhales through mouthpiece 20. This flow of air is noted by detector 2]. Controller 24, responding to the signal of detector 21, then opens valve 25 and energizes high frequency generator 15 which in turn actuates crystal 14 which vibrates horn 12 and porous body 11. The medicament is nebulized into an aerosol having 10 to l2 micron particles which is inspired by the subject. These particles preferentially deposit on the throat and larynx of a patient employing the inhaler.
b. The experiment of part (a) is repeated using a 3 to 5 micron pore size glass frit. An aerosol having 6 to 10 micron particles is formed. This aerosol deposits preferentially in an inhaling patients bronchi.
c. Similarly, when a l to 2 micron frit is used, a 2 to 4 micron aerosol is formed, which deposits preferentially in a patients alveoli.
d. The experiment of part (c) is repeated with one change. Controller 24 is set to deliver only a short pulse of aerosol positioned at the initial portion of the inspiration cycle. In this case, the particles of medicament tiavell to and are primarily deposited in the most distant a V60 1.
EXAMPLE 6 A sample of lower ketones is to be analyzed by flame photometric detector gas chromatograph. An aerosolizer in accord with FIG. 3 is constructed using a bilayer ceramic porous body, the outer layer having an average 9 pore diameter of 2 microns, the inner having a 30 mircon average pore diameter. The mixed ketones are fed to the porous body, a suitable ultrasonic frequency is applied and a suitable carrier gas is fed via inlet 31. An aerosol of ketone is produced by the nebulizer and is carried therefrom by a carrier gas through the chromatograph to a flame photometeric detector where it is analyzed.
We claim as our invention:
1. An ultrasonic nebulizer for atomizing a liquid medicament comprising in combination:
A. a porous solid body having a defined intercommunicating pore structure adapted to receive said liquid medicament, pass said liquid medicament through its pores and discharge said liquid medicament through one of its ends, the diameters of at least 75 percent of the pore openings in said one end being in the range of from 0.5 to 5 microns;
B. means for supplying said liquid medicament to said porous body; and
C. means for vibrating said porous body comprising:
2. The nebulizer according to claim 1 wherein at least 85 percent of said diameters are in said range.
3. The nebulizer according to claim 1 wherein the sizes of said particles are essentially twice the diameters of said pore openings.
4. The nebulizer according to claim 1 wherein the porous body comprises an internal macroporous layer which permits facile passage of said liquid medicament and an outer porous layer whose exterior surface defines said one end.
5. The nebulizer according to claim 1, said nebulizer being adapted to atomize the liquid medicament for inhalation by a patient and including:
D. a mouthpiece for transferring the atomized liquid medicament from said one end of the porous body to the mouth of the patient, one end of which communicates with said one end of the porous body and the other end of which is adapted to be received within the mouth of the patient.
6. An ultrasonic nebulizer for atomizing a liquid according to claim 1 wherein the means for supplying liquid to the pores of the porous solid body comprises means for supplying liquid under pressure to a bore in the antennuator horn, which bore communicates with the pores of the porous solid body.
7. An ultrasonic nebulizer for atomizing a liquid medicament for inhalation by a patient comprising in combination, a cylindrical antennuator horn having a large diameter end and distal therefrom a small diameter end and a passageway extending from the small diameter end coaxially through the horn to an external opening; a porous solid body having external pores of diameter of from 0.5 microns to 5 microns affixed to the small diameter end of the antennuator horn, and having a defined intercommunicating pore structure in communication with the passageway; liquid supply means for supplying the liquid medicament to the external opening of the passageway; vibrating means for vibrating the cylindrical antennuator horn and afiixed porous solid body at a frequency of from about 15 Khz to about Khz; and a mouthpiece one end of which communicates with said external pores and the other end of which is adapted to be received within the mouth of the patient.
8. An ultrasonic nebulizer according to claim 7 including an inspiration responsive detector positioned within the airstream in said mouthpiece and operatively interconnected with said liquid supply means and said vibrating means, said detector being adapted to activate the liquid supply means and vibrating means in response to physical changes it detects within said air stream.

Claims (8)

1. An ultrasonic nebulizer for atomizing a liquid medicament comprising in combination: A. a porous solid body having a defined intercommunicating pore structure adapted to receive said liquid medicament, pass said liquid medicament through its pores and discharge said liquid medicament through one of its ends, the diameters of at least 75 percent of the pore openings in said one end being in the range of from 0.5 to 5 microns; B. means for supplying said liquid medicament to said porous body; and C. means for vibrating said porous body comprising: a. an electronic signal generator; b. a transducer operatively connected to said generator; and c. an antennuator horn interconnecting the transducer and porous solid body, whereby the porous body is vibrated causing the liquid medicament to discharge from said one end as an aerosol, the sizes of the particles thereof being directly proportional to the diameters of said pore openings.
2. The nebulizer according to claim 1 wherein at least 85 percent of said diameters are in said range.
3. The nebulizer according to claim 1 wherein the sizes of said particles are essentially twice the diameters of said pore openings.
4. The nebulizer according to claim 1 wherein the porous body comprises an internal macroporous layer which permits facile passage of said liquid medicament and an outer porous layer whose exterior surface defines said one end.
5. The nebulizer according to claim 1, said nebulizer being adapted to atomize the liquid medicament for inhalation by a patient and including: D. a mouthpiece for transferring the atomized liquid medicament from said one end of the porous body to the mouth of the patient, one end of which communicates with said one end of the porous body and the other end of which is adapted to be received within the mouth of the patient.
6. An ultrasonic nebulizer for atomizing a liquid according to claim 1 wherein the means for supplying liquid to the pores of the porous solid body comprises means for supplying liquid under pressure to a bore in the antennuator horn, which bore communicates with the pores of the porous solid body.
7. An ultrasonic nebulizer for atomizing a liquid medicament for inhalation by a patient comprising in combination, a cylindrical antennuator horn having a large diameter end and distal therefrom a small diameter end and a passageway extending from the small diameter end coaxially through the horn to an external opening; a porous solid body having external pores of diameter of from 0.5 microns to 5 microns affixed to the small diameter end of the antennuator horn, and having a defined intercommunicating pore structure in communication wiTh the passageway; liquid supply means for supplying the liquid medicament to the external opening of the passageway; vibrating means for vibrating the cylindrical antennuator horn and affixed porous solid body at a frequency of from about 15 Khz to about 100 Khz; and a mouthpiece one end of which communicates with said external pores and the other end of which is adapted to be received within the mouth of the patient.
8. An ultrasonic nebulizer according to claim 7 including an inspiration responsive detector positioned within the airstream in said mouthpiece and operatively interconnected with said liquid supply means and said vibrating means, said detector being adapted to activate the liquid supply means and vibrating means in response to physical changes it detects within said airstream.
US00299194A 1972-10-20 1972-10-20 Ultrasonic nebulizer Expired - Lifetime US3812854A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US00299194A US3812854A (en) 1972-10-20 1972-10-20 Ultrasonic nebulizer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00299194A US3812854A (en) 1972-10-20 1972-10-20 Ultrasonic nebulizer

Publications (1)

Publication Number Publication Date
US3812854A true US3812854A (en) 1974-05-28

Family

ID=23153709

Family Applications (1)

Application Number Title Priority Date Filing Date
US00299194A Expired - Lifetime US3812854A (en) 1972-10-20 1972-10-20 Ultrasonic nebulizer

Country Status (1)

Country Link
US (1) US3812854A (en)

Cited By (207)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3912168A (en) * 1975-01-30 1975-10-14 Teledyne Ind Inc Teledyne Aqua Irrigation lavage
US4106503A (en) * 1977-03-11 1978-08-15 Richard R. Rosenthal Metering system for stimulating bronchial spasm
US4109863A (en) * 1977-08-17 1978-08-29 The United States Of America As Represented By The United States Department Of Energy Apparatus for ultrasonic nebulization
US4119096A (en) * 1975-08-25 1978-10-10 Siemens Aktiengesellschaft Medical inhalation device for the treatment of diseases of the respiratory tract
US4261512A (en) * 1979-02-24 1981-04-14 Boehringer Ingelheim Gmbh Inhalation aerosol spray device
US4292973A (en) * 1977-09-25 1981-10-06 Kabushiki Kaisha Kurio-Medikaru Apparatus for refrigeration treatment
US4541966A (en) * 1983-08-25 1985-09-17 Penlon Limited Gas humidifying apparatus and method
EP0156409A2 (en) * 1984-02-23 1985-10-02 Jean Michel Anthony Device for moistening parts of the human body
US4546768A (en) * 1981-12-22 1985-10-15 Feierabend Georg Inhalation apparatus for animals
EP0186280A2 (en) * 1984-11-02 1986-07-02 Robert Landis Breath activated medication spray
EP0200258A2 (en) * 1985-04-29 1986-11-05 Jean Michel Anthony Ultrasonic spraying device
EP0232235A2 (en) * 1986-01-27 1987-08-12 A/S GEA Farmaceutisk Fabrik Medical dosing device for discharge of atomized medicament for inhalation air
US4776990A (en) * 1986-11-14 1988-10-11 Rhinotherm Netzer Sereni Method and apparatus for nebulizing a liquid
JPS63193564U (en) * 1987-06-02 1988-12-13
WO1989006147A1 (en) * 1987-12-31 1989-07-13 Etelä-Hämeen Keuhkovammayhdistys R.Y. Ultrasonic atomizer
WO1992011512A1 (en) * 1990-12-17 1992-07-09 Minnesota Mining And Manufacturing Company Device for measuring a pre-determined volume of liquid flowing there through
WO1992011050A1 (en) * 1990-12-17 1992-07-09 Minnesota Mining And Manufacturing Company Inhaler
US5139016A (en) * 1987-08-07 1992-08-18 Sorin Biomedica S.P.A. Process and device for aerosol generation for pulmonary ventilation scintigraphy
US5152456A (en) * 1989-12-12 1992-10-06 Bespak, Plc Dispensing apparatus having a perforate outlet member and a vibrating device
US5221025A (en) * 1989-05-31 1993-06-22 Conceptair Anstalt Method and mechanical, electrical, or electronic apparatus for dispensing, issuing, or diffusing medicines, fragrances or other liquid or visous substances in the liquid phase or in the gaseous phase
US5259254A (en) * 1991-09-25 1993-11-09 Cetac Technologies, Inc. Sample introduction system for inductively coupled plasma and other gas-phase, or particle, detectors utilizing ultrasonic nebulization, and method of use
GB2273660A (en) * 1992-09-11 1994-06-29 Aid Medic Ltd Nebulizer drug delivery system
DE4300880A1 (en) * 1993-01-15 1994-07-21 Draegerwerk Ag Ultrasonic nebulizer with dosing unit
EP0642802A2 (en) * 1993-08-09 1995-03-15 Disetronic Ag Inhalation device
US5407424A (en) * 1993-02-24 1995-04-18 Scimed Life Systems, Inc. Angioplasty perfusion pump
WO1996001663A1 (en) * 1994-07-11 1996-01-25 Aradigm Corporation Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
US5497763A (en) * 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
US5507277A (en) * 1993-01-29 1996-04-16 Aradigm Corporation Lockout device for controlled release of drug from patient-activateddispenser
WO1996013292A1 (en) * 1994-10-28 1996-05-09 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
WO1996013290A1 (en) * 1994-10-28 1996-05-09 Aradigm Corporation Device for aerosolized delivery of peptide drugs
WO1996013291A1 (en) * 1994-10-28 1996-05-09 Aradigm Corporation Device for aerosolizing narcotics
US5518179A (en) * 1991-12-04 1996-05-21 The Technology Partnership Limited Fluid droplets production apparatus and method
US5522385A (en) * 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5529055A (en) * 1993-06-02 1996-06-25 L'oreal Piezoelectric nebulizing apparatus
WO1996028206A1 (en) * 1995-03-14 1996-09-19 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosating unit
WO1996028205A1 (en) * 1995-03-14 1996-09-19 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosing unit
WO1996030068A1 (en) * 1995-03-31 1996-10-03 Aradigm Corporation Intrapulmonary delivery of hematopoietic drug
WO1996031289A1 (en) 1993-12-07 1996-10-10 Fluid Propulsion Technologies, Inc. Methods and apparatus for dispensing liquids as an atomized spray
US5586550A (en) * 1995-08-31 1996-12-24 Fluid Propulsion Technologies, Inc. Apparatus and methods for the delivery of therapeutic liquids to the respiratory system
NL1001682C2 (en) * 1995-11-17 1997-05-21 R & D Injector Ag Nebulizer device.
WO1997031721A1 (en) * 1996-02-27 1997-09-04 Medix Limited A nebuliser
US5672581A (en) * 1993-01-29 1997-09-30 Aradigm Corporation Method of administration of insulin
US5694919A (en) * 1993-01-29 1997-12-09 Aradigm Corporation Lockout device for controlled release of drug from patient-activated dispenser
US5709202A (en) * 1993-05-21 1998-01-20 Aradigm Corporation Intrapulmonary delivery of aerosolized formulations
US5743250A (en) * 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
EP0844027A1 (en) * 1995-08-07 1998-05-27 Omron Corporation Atomization apparatus and method utilizing surface acoustic waves
US5758637A (en) * 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US5771882A (en) * 1995-09-12 1998-06-30 Siemens Elema Ab Anesthetic administration apparatus which delivers anesthetic in microdroplets
US5792057A (en) * 1993-05-21 1998-08-11 Aradigm Corporation Ventilation imaging using a fine particle aerosol generator
US5819726A (en) * 1993-01-29 1998-10-13 Aradigm Corporation Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease
US5826570A (en) * 1991-03-05 1998-10-27 Aradigm Corporation Delivery of aerosol medications for inspiration
US5829436A (en) * 1996-02-05 1998-11-03 Aradigm Corporation Ventilation imaging using a fine particle aerosol generator
US5873358A (en) * 1993-01-29 1999-02-23 Aradigm Corporation Method of maintaining a diabetic patient's blood glucose level in a desired range
US5884620A (en) * 1993-01-29 1999-03-23 Aradigm Corporation Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US5910301A (en) * 1994-05-13 1999-06-08 Aradigm Corporation Method of intrapulmonary administration of a narcotic drug
US5915378A (en) * 1993-01-29 1999-06-29 Aradigm Corporation Creating an aerosolized formulation of insulin
US5934272A (en) * 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US5970973A (en) * 1993-01-29 1999-10-26 Aradigm Corporation Method of delivering insulin lispro
US6012450A (en) * 1993-01-29 2000-01-11 Aradigm Corporation Intrapulmonary delivery of hematopoietic drug
US6014970A (en) * 1998-06-11 2000-01-18 Aerogen, Inc. Methods and apparatus for storing chemical compounds in a portable inhaler
US6024090A (en) * 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
US6085740A (en) * 1996-02-21 2000-07-11 Aerogen, Inc. Liquid dispensing apparatus and methods
US6098620A (en) * 1993-01-29 2000-08-08 Aradigm Corporation Device for aerosolizing narcotics
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US6138668A (en) * 1991-07-02 2000-10-31 Inhale Therpeutic Systems Method and device for delivering aerosolized medicaments
EP1066850A1 (en) * 1999-07-08 2001-01-10 Siemens-Elema AB Medical Nebulizer
US6192876B1 (en) 1997-12-12 2001-02-27 Astra Aktiebolag Inhalation apparatus and method
WO2001019437A1 (en) 1999-09-16 2001-03-22 Instrumentarium Corporation Nebulizer apparatus
US6205999B1 (en) 1995-04-05 2001-03-27 Aerogen, Inc. Methods and apparatus for storing chemical compounds in a portable inhaler
WO2001032246A1 (en) * 1999-11-05 2001-05-10 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebuliser
US6235177B1 (en) 1999-09-09 2001-05-22 Aerogen, Inc. Method for the construction of an aperture plate for dispensing liquid droplets
US6260549B1 (en) * 1998-06-18 2001-07-17 Clavius Devices, Inc. Breath-activated metered-dose inhaler
WO2001076762A2 (en) 2000-04-12 2001-10-18 Instrumentarium Corporation Method of maximizing the mechanical displacement of a piezoelectric nebulizer apparatus
WO2002036269A1 (en) 2000-10-30 2002-05-10 Instrumentarium Corporation Device and method for detecting and controlling liquid supply to an apparatus discharging liquid
EP1219313A1 (en) 2000-12-29 2002-07-03 Instrumentarium Corporation Liquid discharging apparatus and magneto-shape-memory type valve
EP1219314A1 (en) 2000-12-29 2002-07-03 Instrumentarium Corporation Liquid discharge apparatus having magnetic valve
WO2002087772A1 (en) * 2001-05-02 2002-11-07 Aerogen, Inc. Cymbal-shaped actuator for a nebulizing element
US6543443B1 (en) 2000-07-12 2003-04-08 Aerogen, Inc. Methods and devices for nebulizing fluids
US6543448B1 (en) 1994-09-21 2003-04-08 Inhale Therapeutic Systems, Inc. Apparatus and methods for dispersing dry powder medicaments
US6546929B2 (en) 1998-06-04 2003-04-15 Inhale Therapeutic Systems, Inc. Dry powder dispersing apparatus and methods for their use
US6546927B2 (en) 2001-03-13 2003-04-15 Aerogen, Inc. Methods and apparatus for controlling piezoelectric vibration
US20030072717A1 (en) * 2001-02-23 2003-04-17 Vapotronics, Inc. Inhalation device having an optimized air flow path
US6550472B2 (en) 2001-03-16 2003-04-22 Aerogen, Inc. Devices and methods for nebulizing fluids using flow directors
US6554201B2 (en) 2001-05-02 2003-04-29 Aerogen, Inc. Insert molded aerosol generator and methods
WO2003059423A1 (en) * 2002-01-15 2003-07-24 Aerogen, Inc. Systems and methods for clearing aerosols from the effective anatomic dead space
US20030136402A1 (en) * 2002-01-09 2003-07-24 Brigham And Women's Hospital, Inc. Method for altering the body temperature of a patient using a nebulized mist
US6606989B1 (en) * 1997-05-16 2003-08-19 Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Precise administration of a medicated aerosol via the lungs
US6629646B1 (en) 1991-04-24 2003-10-07 Aerogen, Inc. Droplet ejector with oscillating tapered aperture
US6651650B1 (en) * 1992-04-09 2003-11-25 Omron Corporation Ultrasonic atomizer, ultrasonic inhaler and method of controlling same
US6655376B2 (en) * 1998-04-21 2003-12-02 Pneumoflex Systems L.L.C. Aspiration screening process for assessing post surgery patient's risk for pneumonia
US6679249B2 (en) * 1998-04-21 2004-01-20 Pneumoflex Systems, L.L.C. Apparatus for treatment of chronic obstructive pulmonary disease and associated method
US6681767B1 (en) 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
US20040039755A1 (en) * 2002-06-05 2004-02-26 Matthew Kunze Metadata relationships
US20040050860A1 (en) * 2002-05-10 2004-03-18 Crowder Timothy M. Apparatus, systems and related methods for dispensing and /or evaluating dry powders
US20040055598A1 (en) * 2002-05-10 2004-03-25 Crowder Timothy M. Apparatus, systems and related methods for processing, dispensing and/or evaluating non-pharmaceutical dry powders
US6729334B1 (en) * 1994-06-17 2004-05-04 Trudell Medical Limited Nebulizing catheter system and methods of use and manufacture
US6732944B2 (en) 2001-05-02 2004-05-11 Aerogen, Inc. Base isolated nebulizing device and methods
US20040139968A1 (en) * 2001-03-20 2004-07-22 Aerogen, Inc. Fluid filled ampoules and methods for their use in aerosolizers
US20040153262A1 (en) * 2002-05-10 2004-08-05 Crowder Timothy M. Dry powder dose filling systems and related methods
US6782886B2 (en) 1995-04-05 2004-08-31 Aerogen, Inc. Metering pumps for an aerosolizer
US20040170568A1 (en) * 1997-09-29 2004-09-02 Weers Jeffry G. Stabilized preparations for use in metered dose inhalers
US20040256487A1 (en) * 2003-05-20 2004-12-23 Collins James F. Ophthalmic drug delivery system
WO2005011574A2 (en) * 2003-07-30 2005-02-10 Coifman Robert E Microporous membrane nebulizers
US20050034719A1 (en) * 2001-10-18 2005-02-17 Franz Feiner Inhalation therapy apparatus
US20050042170A1 (en) * 2003-02-14 2005-02-24 The Brigham And Women's Hospital, Inc. Method and device for generating mists and medical uses thereof
US6889690B2 (en) 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US20050103337A1 (en) * 2003-10-27 2005-05-19 Anthony James Hickey Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
US20050109659A1 (en) * 2003-10-27 2005-05-26 Hickey Anthony J. Blister packages with frames and associated methods of fabricating dry powder drug containment systems
US20050125002A1 (en) * 2003-10-31 2005-06-09 George Baran System and method for manipulating a catheter for delivering a substance to a body cavity
US20050133024A1 (en) * 2003-11-25 2005-06-23 Coifman Robert E. Devices for measuring inspiratory airflow
US6948491B2 (en) 2001-03-20 2005-09-27 Aerogen, Inc. Convertible fluid feed system with comformable reservoir and methods
US20050229927A1 (en) * 2004-04-20 2005-10-20 Aerogen, Inc. Ventilation systems and methods employing aerosol generators
US20050267628A1 (en) * 2002-05-10 2005-12-01 Oriel Therapeutics, Inc. Dry powder dose filling systems and related methods
US20050274377A1 (en) * 1993-01-29 2005-12-15 Igor Gonda Method of treating diabetes mellitus in a patient
US6978779B2 (en) 2002-04-19 2005-12-27 Instrumentarium Corp. Vibrating element liquid discharging apparatus having gas pressure sensing
US20060001952A1 (en) * 2004-07-02 2006-01-05 Liekki Oy Method and device for producing optical material, and an optical waveguide
US7040549B2 (en) 1991-04-24 2006-05-09 Aerogen, Inc. Systems and methods for controlling fluid feed to an aerosol generator
US20060097068A1 (en) * 2002-08-02 2006-05-11 Markus Urich Fluid droplet production apparatus and method
US20060102172A1 (en) * 2002-10-30 2006-05-18 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy device
WO2005102431A3 (en) * 2004-04-20 2006-06-22 Aerogen Inc Aerosol delivery apparatus for pressure assisted breathing
US20060164912A1 (en) * 2002-10-15 2006-07-27 Christophe Arnaud Method and device for making a dispersion or an emulsion
US20060237090A1 (en) * 2003-03-11 2006-10-26 Prolitec, S.A. Method and device for nebulisation
US7201167B2 (en) * 2004-04-20 2007-04-10 Aerogen, Inc. Method and composition for the treatment of lung surfactant deficiency or dysfunction
US20070102533A1 (en) * 1999-06-11 2007-05-10 Aradigm Corporation; Universidad De Sevilla Aerosol created by directed flow of fluids and devices and methods for producing same
US20070176017A1 (en) * 2006-01-30 2007-08-02 Berger Harvey L Ultrasonic atomizing nozzle and method
WO2007106386A2 (en) 2006-03-10 2007-09-20 Aradgim Corporation Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations
US7290541B2 (en) * 2004-04-20 2007-11-06 Aerogen, Inc. Aerosol delivery apparatus and method for pressure-assisted breathing systems
US7306787B2 (en) 1997-09-29 2007-12-11 Nektar Therapeutics Engineered particles and methods of use
US7322349B2 (en) * 2000-05-05 2008-01-29 Aerogen, Inc. Apparatus and methods for the delivery of medicaments to the respiratory system
US7331339B2 (en) 2000-05-05 2008-02-19 Aerogen, Inc. Methods and systems for operating an aerosol generator
US20080053431A1 (en) * 1996-05-13 2008-03-06 The Universidad De Sevilla Device and method for creating aerosols for drug delivery
US7360536B2 (en) 2002-01-07 2008-04-22 Aerogen, Inc. Devices and methods for nebulizing fluids for inhalation
US20080257337A1 (en) * 2007-04-19 2008-10-23 Denyer Jonathan S H Ventilator Aerosol Delivery
US20080308096A1 (en) * 2005-02-11 2008-12-18 Pari Pharma Gmbh Aerosol Generating Device and Inhalation Therapy Unit Provided with This Device
US20090022669A1 (en) * 2001-05-21 2009-01-22 Vapotronics, Inc. Compositions for protein delivery via the pulmonary route
EP2050479A2 (en) * 2007-10-16 2009-04-22 General Electric Company Apparatus, system and method for admistering an anesthetic agent for a subject breathing
EP2050478A1 (en) * 2007-10-16 2009-04-22 GE Healthcare Finland Oy Device for delivery and regulation of volatile fluids into inspiratory gas
US20090107503A1 (en) * 1994-06-17 2009-04-30 Trudell Medical Limited Nebulizing catheter system and methods of use and manufacture
US7600511B2 (en) 2001-11-01 2009-10-13 Novartis Pharma Ag Apparatus and methods for delivery of medicament to a respiratory system
EP2119465A1 (en) * 2008-05-16 2009-11-18 Markos Mefar S.P.A. Nebulizer with breathing phase detecting sensor for delivering nebulized drugs to a user
US7628339B2 (en) 1991-04-24 2009-12-08 Novartis Pharma Ag Systems and methods for controlling fluid feed to an aerosol generator
US20090308945A1 (en) * 2008-06-17 2009-12-17 Jacob Loverich Liquid dispensing apparatus using a passive liquid metering method
US7677467B2 (en) * 2002-01-07 2010-03-16 Novartis Pharma Ag Methods and devices for aerosolizing medicament
US7771642B2 (en) 2002-05-20 2010-08-10 Novartis Ag Methods of making an apparatus for providing aerosol for medical treatment
WO2010107958A1 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010107957A2 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010107952A2 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010107955A2 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF BTB AND CNC HOMOLOGY 1, BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR 1 (BACH 1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) SEQUENCE LISTING
WO2010111497A2 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF THE INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1)GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010111468A2 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
WO2010111471A2 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010111464A1 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010111490A2 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF THE THYMIC STROMAL LYMPHOPOIETIN (TSLP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7971588B2 (en) 2000-05-05 2011-07-05 Novartis Ag Methods and systems for operating an aerosol generator
US8012136B2 (en) 2003-05-20 2011-09-06 Optimyst Systems, Inc. Ophthalmic fluid delivery device and method of operation
US8246934B2 (en) 1997-09-29 2012-08-21 Novartis Ag Respiratory dispersion for metered dose inhalers comprising perforated microstructures
WO2012156724A2 (en) 2011-05-16 2012-11-22 The Technology Partnership Plc Separable membrane improvements
US8332020B2 (en) 2010-02-01 2012-12-11 Proteus Digital Health, Inc. Two-wrist data gathering system
US20120318259A1 (en) * 2010-01-12 2012-12-20 Omega Life Science Ltd. Method and apparatus for producing fine concentrated aerosol
US8336545B2 (en) 2000-05-05 2012-12-25 Novartis Pharma Ag Methods and systems for operating an aerosol generator
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US8419638B2 (en) 2007-11-19 2013-04-16 Proteus Digital Health, Inc. Body-associated fluid transport structure evaluation devices
US20130108748A1 (en) * 2011-11-01 2013-05-02 Pepsico., Inc. Dispensing Nozzle with an Ultrasound Activator
US20130267864A1 (en) * 2004-02-20 2013-10-10 Pneumoflex Systems, Llc Nebulizer with intra-oral vibrating mesh
US8616195B2 (en) 2003-07-18 2013-12-31 Novartis Ag Nebuliser for the production of aerosolized medication
US20140034051A1 (en) * 2004-02-20 2014-02-06 Pneumoflex Systems, Llc Nebulizer having horizontal venturi
US20140053835A1 (en) * 2012-02-16 2014-02-27 Capnia, Inc. Gas dispenser with diffusing nosepiece
US8684980B2 (en) 2010-07-15 2014-04-01 Corinthian Ophthalmic, Inc. Drop generating device
US8709484B2 (en) 2000-05-10 2014-04-29 Novartis Ag Phospholipid-based powders for drug delivery
US8715623B2 (en) 2001-12-19 2014-05-06 Novartis Ag Pulmonary delivery of aminoglycoside
US8733935B2 (en) 2010-07-15 2014-05-27 Corinthian Ophthalmic, Inc. Method and system for performing remote treatment and monitoring
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US9087145B2 (en) 2010-07-15 2015-07-21 Eyenovia, Inc. Ophthalmic drug delivery
US9084566B2 (en) 2006-07-07 2015-07-21 Proteus Digital Health, Inc. Smart parenteral administration system
US9108211B2 (en) 2005-05-25 2015-08-18 Nektar Therapeutics Vibration systems and methods
US9125979B2 (en) 2007-10-25 2015-09-08 Proteus Digital Health, Inc. Fluid transfer port information system
US9532597B2 (en) 2012-02-22 2017-01-03 Altria Client Services Llc Electronic smoking article
WO2017006091A1 (en) 2015-07-03 2017-01-12 The Technology Partnership Plc Aerosol apparatus with improved separable membrane
US20170021114A1 (en) * 2014-04-03 2017-01-26 Csl Behring Ag Nebulization of immunoglobulin
WO2017051181A1 (en) 2015-09-22 2017-03-30 The Technology Partnership Plc Liquid nicotine formulation
WO2017064473A1 (en) 2015-10-16 2017-04-20 The Technology Partnership Plc Linear droplet generating device
WO2017075318A1 (en) * 2015-10-30 2017-05-04 Johnson & Johnson Consumer Inc. Aseptic aerosol misting device
WO2017090011A1 (en) * 2015-11-26 2017-06-01 Ferrari Brands S.R.L. Device to deliver a substance
US10052443B2 (en) 2014-10-13 2018-08-21 Omega Life Science Ltd. Nebulizers and uses thereof
US10154923B2 (en) 2010-07-15 2018-12-18 Eyenovia, Inc. Drop generating device
US10195634B2 (en) 2013-07-09 2019-02-05 The Technology Partnership Plc Separable membrane improvements
US10239085B2 (en) 2015-10-30 2019-03-26 Johnson & Johnson Consumer Inc. Aseptic aerosol misting device
US10357060B2 (en) 2016-03-11 2019-07-23 Altria Client Services Llc E-vaping device cartridge holder
US10368580B2 (en) 2016-03-08 2019-08-06 Altria Client Services Llc Combined cartridge for electronic vaping device
US10368581B2 (en) 2016-03-11 2019-08-06 Altria Client Services Llc Multiple dispersion generator e-vaping device
US10433580B2 (en) 2016-03-03 2019-10-08 Altria Client Services Llc Methods to add menthol, botanic materials, and/or non-botanic materials to a cartridge, and/or an electronic vaping device including the cartridge
US10455863B2 (en) 2016-03-03 2019-10-29 Altria Client Services Llc Cartridge for electronic vaping device
CN110721865A (en) * 2019-11-07 2020-01-24 湖南嘉业达电子有限公司 Atomizing device for atomizing essential oil
US10583038B2 (en) 2015-04-10 2020-03-10 Kedalion Therapeutics Piezoelectric dispenser with replaceable ampoule
US10624781B2 (en) 2015-01-12 2020-04-21 Kedalion Therapeutics, Inc. Micro-droplet delivery device and methods
US20200129709A1 (en) * 2018-10-28 2020-04-30 Albert Ky Wearable inspiration synchronic ultrasonic nebulizer-humidifier device
US10639194B2 (en) 2011-12-12 2020-05-05 Eyenovia, Inc. High modulus polymeric ejector mechanism, ejector device, and methods of use
US10799652B2 (en) 2015-01-08 2020-10-13 Convexity Scientific Inc. Nebulizer device
US10857311B2 (en) 2010-01-12 2020-12-08 Omega Life Science Ltd. Method and apparatus for producing fine concentrated aerosol
US10888454B2 (en) 2017-01-20 2021-01-12 Kedalion Therapeutics, Inc. Piezoelectric fluid dispenser
US11278448B2 (en) 2017-12-08 2022-03-22 Kedalion Therapeutics, Inc. Fluid delivery alignment system
US11298472B2 (en) * 2020-04-24 2022-04-12 SOSD Health & Medical Innovations Inc. Ultrasonic nebulizer
US11571704B2 (en) 2015-10-30 2023-02-07 Johnson & Johnson Consumer Inc. Aseptic aerosol misting device
US11583885B2 (en) 2015-10-30 2023-02-21 Johnson & Johnson Consumer Inc. Unit dose aseptic aerosol misting device
US11679028B2 (en) 2019-03-06 2023-06-20 Novartis Ag Multi-dose ocular fluid delivery system
US11925577B2 (en) 2021-04-16 2024-03-12 Bausch + Lomb Ireland Limted Hydrodynamically actuated preservative free dispensing system

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2658169A (en) * 1948-03-18 1953-11-03 Centre Nat Rech Scient Production of aerosols
US2949900A (en) * 1958-06-02 1960-08-23 Albert G Bodine Sonic liquid sprayer
US3121534A (en) * 1960-09-29 1964-02-18 Exxon Research Engineering Co Supersonic liquid atomizer and electronic oscillator therefor
US3214101A (en) * 1964-03-31 1965-10-26 Little Inc A Apparatus for atomizing a liquid
US3243122A (en) * 1965-02-24 1966-03-29 Alvin A Snaper Ultrasonic spray apparatus
US3400892A (en) * 1965-12-02 1968-09-10 Battelle Development Corp Resonant vibratory apparatus
US3561444A (en) * 1968-05-22 1971-02-09 Bio Logics Inc Ultrasonic drug nebulizer
US3653379A (en) * 1970-08-20 1972-04-04 Joseph G Glenn Adjustable pressure ippb ventilator

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2658169A (en) * 1948-03-18 1953-11-03 Centre Nat Rech Scient Production of aerosols
US2949900A (en) * 1958-06-02 1960-08-23 Albert G Bodine Sonic liquid sprayer
US3121534A (en) * 1960-09-29 1964-02-18 Exxon Research Engineering Co Supersonic liquid atomizer and electronic oscillator therefor
US3214101A (en) * 1964-03-31 1965-10-26 Little Inc A Apparatus for atomizing a liquid
US3243122A (en) * 1965-02-24 1966-03-29 Alvin A Snaper Ultrasonic spray apparatus
US3400892A (en) * 1965-12-02 1968-09-10 Battelle Development Corp Resonant vibratory apparatus
US3561444A (en) * 1968-05-22 1971-02-09 Bio Logics Inc Ultrasonic drug nebulizer
US3653379A (en) * 1970-08-20 1972-04-04 Joseph G Glenn Adjustable pressure ippb ventilator

Cited By (388)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3912168A (en) * 1975-01-30 1975-10-14 Teledyne Ind Inc Teledyne Aqua Irrigation lavage
US4119096A (en) * 1975-08-25 1978-10-10 Siemens Aktiengesellschaft Medical inhalation device for the treatment of diseases of the respiratory tract
US4106503A (en) * 1977-03-11 1978-08-15 Richard R. Rosenthal Metering system for stimulating bronchial spasm
US4109863A (en) * 1977-08-17 1978-08-29 The United States Of America As Represented By The United States Department Of Energy Apparatus for ultrasonic nebulization
US4292973A (en) * 1977-09-25 1981-10-06 Kabushiki Kaisha Kurio-Medikaru Apparatus for refrigeration treatment
US4348873A (en) * 1977-09-25 1982-09-14 Kabushiki Kaisha Kurio-Medikaru Apparatus for refrigeration treatment
US4412538A (en) * 1977-09-25 1983-11-01 Kabushiki Kaisha Kurio-Medikaru Apparatus for refrigeration treatment
US4261512A (en) * 1979-02-24 1981-04-14 Boehringer Ingelheim Gmbh Inhalation aerosol spray device
US4546768A (en) * 1981-12-22 1985-10-15 Feierabend Georg Inhalation apparatus for animals
US4541966A (en) * 1983-08-25 1985-09-17 Penlon Limited Gas humidifying apparatus and method
EP0156409A2 (en) * 1984-02-23 1985-10-02 Jean Michel Anthony Device for moistening parts of the human body
EP0156409A3 (en) * 1984-02-23 1986-06-25 Jean Michel Anthony Device for moistening parts of the human body
US4648393A (en) * 1984-11-02 1987-03-10 Ackrad Laboratories, Inc. Breath activated medication spray
EP0186280A2 (en) * 1984-11-02 1986-07-02 Robert Landis Breath activated medication spray
EP0186280A3 (en) * 1984-11-02 1988-01-13 Robert Landis Breath activated medication spray
US4815661A (en) * 1985-04-29 1989-03-28 Tomtec N.V. Ultrasonic spraying device
EP0200258A2 (en) * 1985-04-29 1986-11-05 Jean Michel Anthony Ultrasonic spraying device
EP0200258A3 (en) * 1985-04-29 1988-02-03 Jean Michel Anthony Ultrasonic spraying device
EP0232235A3 (en) * 1986-01-27 1989-05-03 A/S GEA Farmaceutisk Fabrik Medical dosing device for discharge of atomized medicament for inhalation air
EP0232235A2 (en) * 1986-01-27 1987-08-12 A/S GEA Farmaceutisk Fabrik Medical dosing device for discharge of atomized medicament for inhalation air
US4776990A (en) * 1986-11-14 1988-10-11 Rhinotherm Netzer Sereni Method and apparatus for nebulizing a liquid
JPS63193564U (en) * 1987-06-02 1988-12-13
JPH0545407Y2 (en) * 1987-06-02 1993-11-19
US5139016A (en) * 1987-08-07 1992-08-18 Sorin Biomedica S.P.A. Process and device for aerosol generation for pulmonary ventilation scintigraphy
WO1989006147A1 (en) * 1987-12-31 1989-07-13 Etelä-Hämeen Keuhkovammayhdistys R.Y. Ultrasonic atomizer
GB2219512A (en) * 1987-12-31 1989-12-13 Etelae Haemeen Keuhkovammayhdi Ultrasonic atomizer
GB2219512B (en) * 1987-12-31 1991-09-04 Etelae Haemeen Keuhkovammayhdi Ultrasonic atomizer
US5063922A (en) * 1987-12-31 1991-11-12 Etala-Hameen Keuhkovammayhdistys R.Y. Ultrasonic atomizer
US5221025A (en) * 1989-05-31 1993-06-22 Conceptair Anstalt Method and mechanical, electrical, or electronic apparatus for dispensing, issuing, or diffusing medicines, fragrances or other liquid or visous substances in the liquid phase or in the gaseous phase
US5261601A (en) * 1989-12-12 1993-11-16 Bespak Plc Liquid dispensing apparatus having a vibrating perforate membrane
US5152456A (en) * 1989-12-12 1992-10-06 Bespak, Plc Dispensing apparatus having a perforate outlet member and a vibrating device
WO1992011512A1 (en) * 1990-12-17 1992-07-09 Minnesota Mining And Manufacturing Company Device for measuring a pre-determined volume of liquid flowing there through
US5392648A (en) * 1990-12-17 1995-02-28 Minnesota Mining And Manufacturing Company Device for measuring a pre-determined volume of liquid flowing therethrough
WO1992011050A1 (en) * 1990-12-17 1992-07-09 Minnesota Mining And Manufacturing Company Inhaler
US5487378A (en) * 1990-12-17 1996-01-30 Minnesota Mining And Manufacturing Company Inhaler
US5826570A (en) * 1991-03-05 1998-10-27 Aradigm Corporation Delivery of aerosol medications for inspiration
US7083112B2 (en) 1991-04-24 2006-08-01 Aerogen, Inc. Method and apparatus for dispensing liquids as an atomized spray
US7628339B2 (en) 1991-04-24 2009-12-08 Novartis Pharma Ag Systems and methods for controlling fluid feed to an aerosol generator
US5938117A (en) * 1991-04-24 1999-08-17 Aerogen, Inc. Methods and apparatus for dispensing liquids as an atomized spray
US6540153B1 (en) 1991-04-24 2003-04-01 Aerogen, Inc. Methods and apparatus for dispensing liquids as an atomized spray
US20070075161A1 (en) * 1991-04-24 2007-04-05 Aerogen, Inc. Droplet Ejector With Oscillating Tapered Aperture
US7108197B2 (en) * 1991-04-24 2006-09-19 Aerogen, Inc. Droplet ejector with oscillating tapered aperture
US20050279851A1 (en) * 1991-04-24 2005-12-22 Aerogen, Inc. Method and apparatus for dispensing liquids as an atomized spray
US6629646B1 (en) 1991-04-24 2003-10-07 Aerogen, Inc. Droplet ejector with oscillating tapered aperture
US20030226906A1 (en) * 1991-04-24 2003-12-11 Aerogen, Inc. Droplet ejector with oscillating tapered aperture
US7040549B2 (en) 1991-04-24 2006-05-09 Aerogen, Inc. Systems and methods for controlling fluid feed to an aerosol generator
US20050263608A1 (en) * 1991-04-24 2005-12-01 Aerogen, Inc. Droplet ejector with oscillating tapered aperture
US6926208B2 (en) 1991-04-24 2005-08-09 Aerogen, Inc. Droplet ejector with oscillating tapered aperture
US6138668A (en) * 1991-07-02 2000-10-31 Inhale Therpeutic Systems Method and device for delivering aerosolized medicaments
US20050279349A1 (en) * 1991-07-02 2005-12-22 Patton John S Method and device for delivering aerosolized medicaments
US6681767B1 (en) 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
US5259254A (en) * 1991-09-25 1993-11-09 Cetac Technologies, Inc. Sample introduction system for inductively coupled plasma and other gas-phase, or particle, detectors utilizing ultrasonic nebulization, and method of use
US5518179A (en) * 1991-12-04 1996-05-21 The Technology Partnership Limited Fluid droplets production apparatus and method
US6651650B1 (en) * 1992-04-09 2003-11-25 Omron Corporation Ultrasonic atomizer, ultrasonic inhaler and method of controlling same
GB2273660B (en) * 1992-09-11 1996-07-17 Aid Medic Ltd Drug delivery arrangement
US6116233A (en) * 1992-09-11 2000-09-12 Medic-Aid Limited Drug delivery arrangement
GB2273660A (en) * 1992-09-11 1994-06-29 Aid Medic Ltd Nebulizer drug delivery system
DE4300880A1 (en) * 1993-01-15 1994-07-21 Draegerwerk Ag Ultrasonic nebulizer with dosing unit
US5443059A (en) * 1993-01-15 1995-08-22 Dragerwerk Ag Ultrasonic atomizer with a metering unit
US5819726A (en) * 1993-01-29 1998-10-13 Aradigm Corporation Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease
US20090241950A1 (en) * 1993-01-29 2009-10-01 Aradigm Corporation Method of treating diabetes mellitus in a patient
US7490603B2 (en) * 1993-01-29 2009-02-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US6024090A (en) * 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
US7021309B2 (en) * 1993-01-29 2006-04-04 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5672581A (en) * 1993-01-29 1997-09-30 Aradigm Corporation Method of administration of insulin
US5694919A (en) * 1993-01-29 1997-12-09 Aradigm Corporation Lockout device for controlled release of drug from patient-activated dispenser
US7028686B2 (en) * 1993-01-29 2006-04-18 Aradigm Corporation Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US20040089290A1 (en) * 1993-01-29 2004-05-13 Aradigm Corporation Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US5724957A (en) * 1993-01-29 1998-03-10 Aradigm Corporation Intrapulmonary delivery of narcotics
US20080264416A1 (en) * 1993-01-29 2008-10-30 Novo Nordisk A/S Method of Treating Diabetes Mellitus in a Patient
US20040062722A1 (en) * 1993-01-29 2004-04-01 Igor Gonda Method of use of monomeric insulin as a means for improving the reproducibilty of inhaled insulin
US6431167B1 (en) * 1993-01-29 2002-08-13 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US6688304B2 (en) * 1993-01-29 2004-02-10 Aradigm Corporation Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US20060093556A1 (en) * 1993-01-29 2006-05-04 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5507277A (en) * 1993-01-29 1996-04-16 Aradigm Corporation Lockout device for controlled release of drug from patient-activateddispenser
US6085753A (en) * 1993-01-29 2000-07-11 Aradigm Corporation Insulin delivery enhanced by coached breathing
US6647987B2 (en) 1993-01-29 2003-11-18 Aradigm Corporation Insulin delivery enhanced by coached breathing
US20060124125A1 (en) * 1993-01-29 2006-06-15 Igor Gonda Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US7448375B2 (en) 1993-01-29 2008-11-11 Aradigm Corporation Method of treating diabetes mellitus in a patient
US5735263A (en) * 1993-01-29 1998-04-07 Aradigm Corporation Lockout device for controlled release of drug from patient-activated dispenser
US20080099010A1 (en) * 1993-01-29 2008-05-01 Igor Gonda Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5743250A (en) * 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
US5873358A (en) * 1993-01-29 1999-02-23 Aradigm Corporation Method of maintaining a diabetic patient's blood glucose level in a desired range
US5884620A (en) * 1993-01-29 1999-03-23 Aradigm Corporation Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US5888477A (en) * 1993-01-29 1999-03-30 Aradigm Corporation Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
US6431166B2 (en) 1993-01-29 2002-08-13 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5915378A (en) * 1993-01-29 1999-06-29 Aradigm Corporation Creating an aerosolized formulation of insulin
US6427681B1 (en) 1993-01-29 2002-08-06 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US6408854B1 (en) 1993-01-29 2002-06-25 Aradigm Corporation Insulin delivery enhanced by coached breathing
US6250298B1 (en) 1993-01-29 2001-06-26 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5934272A (en) * 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US20080099011A1 (en) * 1993-01-29 2008-05-01 Novo Nordisk Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US5941240A (en) * 1993-01-29 1999-08-24 Aradigm Corporation Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US6167880B1 (en) 1993-01-29 2001-01-02 Aradigm Corporation Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US5558085A (en) * 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5960792A (en) * 1993-01-29 1999-10-05 Aradigm Corporation Device for aerosolized delivery of peptide drugs
US5970973A (en) * 1993-01-29 1999-10-26 Aradigm Corporation Method of delivering insulin lispro
US20050274377A1 (en) * 1993-01-29 2005-12-15 Igor Gonda Method of treating diabetes mellitus in a patient
US6012450A (en) * 1993-01-29 2000-01-11 Aradigm Corporation Intrapulmonary delivery of hematopoietic drug
US6098615A (en) * 1993-01-29 2000-08-08 Aradigm Corporation Method of reproducibly effecting a patient's glucose level
US6098620A (en) * 1993-01-29 2000-08-08 Aradigm Corporation Device for aerosolizing narcotics
US5407424A (en) * 1993-02-24 1995-04-18 Scimed Life Systems, Inc. Angioplasty perfusion pump
US5544646A (en) * 1993-05-21 1996-08-13 Aradigm Corporation Systems for the intrapulmonary delivery of aerosolized aqueous formulations
US5823178A (en) * 1993-05-21 1998-10-20 Aradigm Corporation Disposable package for use in aerosolized delivery of drugs
US6014969A (en) * 1993-05-21 2000-01-18 Aradigm Corporation Disposable package for use in aerosolized delivery of antibiotics
US5792057A (en) * 1993-05-21 1998-08-11 Aradigm Corporation Ventilation imaging using a fine particle aerosol generator
US5718222A (en) * 1993-05-21 1998-02-17 Aradigm Corporation Disposable package for use in aerosolized delivery of drugs
US6123068A (en) * 1993-05-21 2000-09-26 Aradigm Corporation Systems for the intrapulmonary delivery of aerosolized aqueous formulations
US5709202A (en) * 1993-05-21 1998-01-20 Aradigm Corporation Intrapulmonary delivery of aerosolized formulations
AU690561B2 (en) * 1993-05-21 1998-04-30 Aradigm Corporation The intrapulmonary delivery of aerosolized aqueous formulations
US5497763A (en) * 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
US5660166A (en) * 1993-05-21 1997-08-26 Aradigm Corporation Systems for the intrapulmonary delivery of aerosolized aqueous formulations
US5529055A (en) * 1993-06-02 1996-06-25 L'oreal Piezoelectric nebulizing apparatus
EP0642802A3 (en) * 1993-08-09 1996-03-13 Disetronic Ag Inhalation device.
EP0642802A2 (en) * 1993-08-09 1995-03-15 Disetronic Ag Inhalation device
WO1996031289A1 (en) 1993-12-07 1996-10-10 Fluid Propulsion Technologies, Inc. Methods and apparatus for dispensing liquids as an atomized spray
US5910301A (en) * 1994-05-13 1999-06-08 Aradigm Corporation Method of intrapulmonary administration of a narcotic drug
US7469700B2 (en) 1994-06-17 2008-12-30 Trudell Medical Limited Nebulizing catheter system for delivering an aerosol to a patient
US6729334B1 (en) * 1994-06-17 2004-05-04 Trudell Medical Limited Nebulizing catheter system and methods of use and manufacture
US7472705B2 (en) 1994-06-17 2009-01-06 Trudell Medical Limited Methods of forming a nebulizing catheter
US20090107503A1 (en) * 1994-06-17 2009-04-30 Trudell Medical Limited Nebulizing catheter system and methods of use and manufacture
WO1996001663A1 (en) * 1994-07-11 1996-01-25 Aradigm Corporation Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
US5509404A (en) * 1994-07-11 1996-04-23 Aradigm Corporation Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
EP1310268A3 (en) * 1994-07-11 2003-11-26 Aradigm Corporation Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
US6543448B1 (en) 1994-09-21 2003-04-08 Inhale Therapeutic Systems, Inc. Apparatus and methods for dispersing dry powder medicaments
US5957124A (en) * 1994-09-27 1999-09-28 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5522385A (en) * 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
JPH11508456A (en) * 1994-10-28 1999-07-27 アラディグム コーポレーション Device to convert anesthetic into aerosol
AU709572B2 (en) * 1994-10-28 1999-09-02 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
AU708150B2 (en) * 1994-10-28 1999-07-29 Aradigm Corporation Device for aerosolizing narcotics
JPH10508230A (en) * 1994-10-28 1998-08-18 アラディグム コーポレーション Apparatus and method for producing aerosolized sprays of respiratory drugs
WO1996013290A1 (en) * 1994-10-28 1996-05-09 Aradigm Corporation Device for aerosolized delivery of peptide drugs
AU708269B2 (en) * 1994-10-28 1999-07-29 Aradigm Corporation Device for aerosolized delivery of peptide drugs
WO1996013291A1 (en) * 1994-10-28 1996-05-09 Aradigm Corporation Device for aerosolizing narcotics
WO1996013292A1 (en) * 1994-10-28 1996-05-09 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
AU690438B2 (en) * 1995-03-14 1998-04-23 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosating unit
WO1996028206A1 (en) * 1995-03-14 1996-09-19 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosating unit
US5950619A (en) * 1995-03-14 1999-09-14 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosating unit
WO1996028205A1 (en) * 1995-03-14 1996-09-19 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosing unit
US5970974A (en) * 1995-03-14 1999-10-26 Siemens Aktiengesellschaft Dosating unit for an ultrasonic atomizer device
WO1996030068A1 (en) * 1995-03-31 1996-10-03 Aradigm Corporation Intrapulmonary delivery of hematopoietic drug
US20070209659A1 (en) * 1995-04-05 2007-09-13 Aerogen, Inc. Liquid dispensing apparatus and methods
US6467476B1 (en) 1995-04-05 2002-10-22 Aerogen, Inc. Liquid dispensing apparatus and methods
US8561604B2 (en) 1995-04-05 2013-10-22 Novartis Ag Liquid dispensing apparatus and methods
US7174888B2 (en) 1995-04-05 2007-02-13 Aerogen, Inc. Liquid dispensing apparatus and methods
US6755189B2 (en) 1995-04-05 2004-06-29 Aerogen, Inc. Methods and apparatus for storing chemical compounds in a portable inhaler
US6205999B1 (en) 1995-04-05 2001-03-27 Aerogen, Inc. Methods and apparatus for storing chemical compounds in a portable inhaler
US6640804B2 (en) 1995-04-05 2003-11-04 Aerogen, Inc. Liquid dispensing apparatus and methods
US6782886B2 (en) 1995-04-05 2004-08-31 Aerogen, Inc. Metering pumps for an aerosolizer
EP0844027A4 (en) * 1995-08-07 2001-06-13 Omron Tateisi Electronics Co Atomization apparatus and method utilizing surface acoustic waves
EP0844027A1 (en) * 1995-08-07 1998-05-27 Omron Corporation Atomization apparatus and method utilizing surface acoustic waves
US5586550A (en) * 1995-08-31 1996-12-24 Fluid Propulsion Technologies, Inc. Apparatus and methods for the delivery of therapeutic liquids to the respiratory system
US5758637A (en) * 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US5771882A (en) * 1995-09-12 1998-06-30 Siemens Elema Ab Anesthetic administration apparatus which delivers anesthetic in microdroplets
NL1001682C2 (en) * 1995-11-17 1997-05-21 R & D Injector Ag Nebulizer device.
WO1997018846A1 (en) * 1995-11-17 1997-05-29 R + D Injector Ag Nebulizing device
US5829436A (en) * 1996-02-05 1998-11-03 Aradigm Corporation Ventilation imaging using a fine particle aerosol generator
US6085740A (en) * 1996-02-21 2000-07-11 Aerogen, Inc. Liquid dispensing apparatus and methods
WO1997031721A1 (en) * 1996-02-27 1997-09-04 Medix Limited A nebuliser
US8733343B2 (en) * 1996-05-13 2014-05-27 Universidad De Sevilla Device and method for creating aerosols for drug delivery
US20080053431A1 (en) * 1996-05-13 2008-03-06 The Universidad De Sevilla Device and method for creating aerosols for drug delivery
US6606989B1 (en) * 1997-05-16 2003-08-19 Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Precise administration of a medicated aerosol via the lungs
US20040170568A1 (en) * 1997-09-29 2004-09-02 Weers Jeffry G. Stabilized preparations for use in metered dose inhalers
US7306787B2 (en) 1997-09-29 2007-12-11 Nektar Therapeutics Engineered particles and methods of use
US8246934B2 (en) 1997-09-29 2012-08-21 Novartis Ag Respiratory dispersion for metered dose inhalers comprising perforated microstructures
US9554993B2 (en) 1997-09-29 2017-01-31 Novartis Ag Pulmonary delivery particles comprising an active agent
US7628978B2 (en) 1997-09-29 2009-12-08 Novartis Pharma Ag Stabilized preparations for use in metered dose inhalers
US8168223B1 (en) 1997-09-29 2012-05-01 Novartis Pharma Ag Engineered particles and methods of use
US6192876B1 (en) 1997-12-12 2001-02-27 Astra Aktiebolag Inhalation apparatus and method
US6655376B2 (en) * 1998-04-21 2003-12-02 Pneumoflex Systems L.L.C. Aspiration screening process for assessing post surgery patient's risk for pneumonia
US6679249B2 (en) * 1998-04-21 2004-01-20 Pneumoflex Systems, L.L.C. Apparatus for treatment of chronic obstructive pulmonary disease and associated method
US8161969B2 (en) 1998-06-04 2012-04-24 Novartis Ag Dry powder dispersing apparatus and methods for their use
US20030209243A1 (en) * 1998-06-04 2003-11-13 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
US7422013B2 (en) 1998-06-04 2008-09-09 Nektar Therapeutics Dry powder dispersing apparatus and methods for their use
US6546929B2 (en) 1998-06-04 2003-04-15 Inhale Therapeutic Systems, Inc. Dry powder dispersing apparatus and methods for their use
US6901929B2 (en) 1998-06-04 2005-06-07 Nektar Therapeutics Dry powder dispersing apparatus and methods for their use
US20080230058A1 (en) * 1998-06-04 2008-09-25 Nektar Therapeutics Dry powder dispersing apparatus and methods for their use
US8578931B2 (en) 1998-06-11 2013-11-12 Novartis Ag Methods and apparatus for storing chemical compounds in a portable inhaler
US6014970A (en) * 1998-06-11 2000-01-18 Aerogen, Inc. Methods and apparatus for storing chemical compounds in a portable inhaler
US6318361B1 (en) * 1998-06-18 2001-11-20 Clavius Devices Inc. Breath-activated metered-dose inhaler
US6260549B1 (en) * 1998-06-18 2001-07-17 Clavius Devices, Inc. Breath-activated metered-dose inhaler
US20080053436A1 (en) * 1999-06-11 2008-03-06 Aradigm Corporation Aerosol created by directed flow of fluids and devices and methods for producing same
US20070102533A1 (en) * 1999-06-11 2007-05-10 Aradigm Corporation; Universidad De Sevilla Aerosol created by directed flow of fluids and devices and methods for producing same
US6598602B1 (en) 1999-07-08 2003-07-29 Siemens-Elema Ab Medical nebulizer
EP1066850A1 (en) * 1999-07-08 2001-01-10 Siemens-Elema AB Medical Nebulizer
US8398001B2 (en) 1999-09-09 2013-03-19 Novartis Ag Aperture plate and methods for its construction and use
US20070023547A1 (en) * 1999-09-09 2007-02-01 Aerogen, Inc. Aperture plate and methods for its construction and use
US7066398B2 (en) 1999-09-09 2006-06-27 Aerogen, Inc. Aperture plate and methods for its construction and use
US6235177B1 (en) 1999-09-09 2001-05-22 Aerogen, Inc. Method for the construction of an aperture plate for dispensing liquid droplets
US6530370B1 (en) 1999-09-16 2003-03-11 Instrumentation Corp. Nebulizer apparatus
WO2001019437A1 (en) 1999-09-16 2001-03-22 Instrumentarium Corporation Nebulizer apparatus
EP1227856A1 (en) * 1999-11-05 2002-08-07 PARI GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
WO2001032246A1 (en) * 1999-11-05 2001-05-10 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebuliser
EP1227856A4 (en) * 1999-11-05 2007-01-03 Pari Gmbh Inhalation nebulizer
US6539937B1 (en) 2000-04-12 2003-04-01 Instrumentarium Corp. Method of maximizing the mechanical displacement of a piezoelectric nebulizer apparatus
WO2001076762A2 (en) 2000-04-12 2001-10-18 Instrumentarium Corporation Method of maximizing the mechanical displacement of a piezoelectric nebulizer apparatus
US7322349B2 (en) * 2000-05-05 2008-01-29 Aerogen, Inc. Apparatus and methods for the delivery of medicaments to the respiratory system
US7971588B2 (en) 2000-05-05 2011-07-05 Novartis Ag Methods and systems for operating an aerosol generator
US7748377B2 (en) 2000-05-05 2010-07-06 Novartis Ag Methods and systems for operating an aerosol generator
US7331339B2 (en) 2000-05-05 2008-02-19 Aerogen, Inc. Methods and systems for operating an aerosol generator
US8336545B2 (en) 2000-05-05 2012-12-25 Novartis Pharma Ag Methods and systems for operating an aerosol generator
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US9439862B2 (en) 2000-05-10 2016-09-13 Novartis Ag Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US8709484B2 (en) 2000-05-10 2014-04-29 Novartis Ag Phospholipid-based powders for drug delivery
US8349294B2 (en) 2000-05-10 2013-01-08 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8877162B2 (en) 2000-05-10 2014-11-04 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery
US6543443B1 (en) 2000-07-12 2003-04-08 Aerogen, Inc. Methods and devices for nebulizing fluids
US6769626B1 (en) 2000-10-30 2004-08-03 Instrumentarium Corp. Device and method for detecting and controlling liquid supply to an apparatus discharging liquids
WO2002036269A1 (en) 2000-10-30 2002-05-10 Instrumentarium Corporation Device and method for detecting and controlling liquid supply to an apparatus discharging liquid
EP1219314A1 (en) 2000-12-29 2002-07-03 Instrumentarium Corporation Liquid discharge apparatus having magnetic valve
EP1219313A1 (en) 2000-12-29 2002-07-03 Instrumentarium Corporation Liquid discharging apparatus and magneto-shape-memory type valve
US8201554B2 (en) 2001-02-23 2012-06-19 Injet Digital Aerosols Limited Inhalation device having an optimized air flow path
US20030072717A1 (en) * 2001-02-23 2003-04-17 Vapotronics, Inc. Inhalation device having an optimized air flow path
US20090173341A1 (en) * 2001-02-23 2009-07-09 Injet Digital Aerosols Limited Inhalation device having an optimized air flow path
US6546927B2 (en) 2001-03-13 2003-04-15 Aerogen, Inc. Methods and apparatus for controlling piezoelectric vibration
US6550472B2 (en) 2001-03-16 2003-04-22 Aerogen, Inc. Devices and methods for nebulizing fluids using flow directors
US6948491B2 (en) 2001-03-20 2005-09-27 Aerogen, Inc. Convertible fluid feed system with comformable reservoir and methods
US7195011B2 (en) 2001-03-20 2007-03-27 Aerogen, Inc. Convertible fluid feed system with comformable reservoir and methods
US8196573B2 (en) 2001-03-20 2012-06-12 Novartis Ag Methods and systems for operating an aerosol generator
US20040139968A1 (en) * 2001-03-20 2004-07-22 Aerogen, Inc. Fluid filled ampoules and methods for their use in aerosolizers
US7032590B2 (en) 2001-03-20 2006-04-25 Aerogen, Inc. Fluid filled ampoules and methods for their use in aerosolizers
US7100600B2 (en) 2001-03-20 2006-09-05 Aerogen, Inc. Fluid filled ampoules and methods for their use in aerosolizers
US6978941B2 (en) 2001-05-02 2005-12-27 Aerogen, Inc. Base isolated nebulizing device and methods
WO2002087772A1 (en) * 2001-05-02 2002-11-07 Aerogen, Inc. Cymbal-shaped actuator for a nebulizing element
US6554201B2 (en) 2001-05-02 2003-04-29 Aerogen, Inc. Insert molded aerosol generator and methods
US6732944B2 (en) 2001-05-02 2004-05-11 Aerogen, Inc. Base isolated nebulizing device and methods
US7104463B2 (en) 2001-05-02 2006-09-12 Aerogen, Inc. Base isolated nebulizing device and methods
US20090022669A1 (en) * 2001-05-21 2009-01-22 Vapotronics, Inc. Compositions for protein delivery via the pulmonary route
US20050034719A1 (en) * 2001-10-18 2005-02-17 Franz Feiner Inhalation therapy apparatus
US7600511B2 (en) 2001-11-01 2009-10-13 Novartis Pharma Ag Apparatus and methods for delivery of medicament to a respiratory system
US9421166B2 (en) 2001-12-19 2016-08-23 Novartis Ag Pulmonary delivery of aminoglycoside
US8715623B2 (en) 2001-12-19 2014-05-06 Novartis Ag Pulmonary delivery of aminoglycoside
US7677467B2 (en) * 2002-01-07 2010-03-16 Novartis Pharma Ag Methods and devices for aerosolizing medicament
US7360536B2 (en) 2002-01-07 2008-04-22 Aerogen, Inc. Devices and methods for nebulizing fluids for inhalation
US8539944B2 (en) 2002-01-07 2013-09-24 Novartis Ag Devices and methods for nebulizing fluids for inhalation
US20030136402A1 (en) * 2002-01-09 2003-07-24 Brigham And Women's Hospital, Inc. Method for altering the body temperature of a patient using a nebulized mist
US7201163B2 (en) * 2002-01-09 2007-04-10 The Brigham And Women's Hospital, Inc. Method for altering the body temperature of a patient using a nebulized mist
WO2003059423A1 (en) * 2002-01-15 2003-07-24 Aerogen, Inc. Systems and methods for clearing aerosols from the effective anatomic dead space
US6845770B2 (en) 2002-01-15 2005-01-25 Aerogen, Inc. Systems and methods for clearing aerosols from the effective anatomic dead space
US6978779B2 (en) 2002-04-19 2005-12-27 Instrumentarium Corp. Vibrating element liquid discharging apparatus having gas pressure sensing
US20050267628A1 (en) * 2002-05-10 2005-12-01 Oriel Therapeutics, Inc. Dry powder dose filling systems and related methods
US7118010B2 (en) 2002-05-10 2006-10-10 Oriel Therapeutics, Inc. Apparatus, systems and related methods for dispensing and /or evaluating dry powders
US20040055598A1 (en) * 2002-05-10 2004-03-25 Crowder Timothy M. Apparatus, systems and related methods for processing, dispensing and/or evaluating non-pharmaceutical dry powders
US7428446B2 (en) 2002-05-10 2008-09-23 Oriel Therapeutics, Inc. Dry powder dose filling systems and related methods
US7677411B2 (en) 2002-05-10 2010-03-16 Oriel Therapeutics, Inc. Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
US6985798B2 (en) 2002-05-10 2006-01-10 Oriel Therapeutics, Inc. Dry powder dose filling systems and related methods
US6889690B2 (en) 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US20040153262A1 (en) * 2002-05-10 2004-08-05 Crowder Timothy M. Dry powder dose filling systems and related methods
US20050126569A1 (en) * 2002-05-10 2005-06-16 Crowder Timothy M. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US7520278B2 (en) 2002-05-10 2009-04-21 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US20040050860A1 (en) * 2002-05-10 2004-03-18 Crowder Timothy M. Apparatus, systems and related methods for dispensing and /or evaluating dry powders
US7771642B2 (en) 2002-05-20 2010-08-10 Novartis Ag Methods of making an apparatus for providing aerosol for medical treatment
US20040039755A1 (en) * 2002-06-05 2004-02-26 Matthew Kunze Metadata relationships
US20060097068A1 (en) * 2002-08-02 2006-05-11 Markus Urich Fluid droplet production apparatus and method
US7931212B2 (en) 2002-08-02 2011-04-26 Pari Pharma Gmbh Fluid droplet production apparatus and method
US20110155768A1 (en) * 2002-08-02 2011-06-30 Pari Pharma Gmbh Fluid droplet production apparatus and method
US8511581B2 (en) 2002-08-02 2013-08-20 Pari Pharma Gmbh Fluid droplet production apparatus and method
US7622510B2 (en) * 2002-10-15 2009-11-24 Christophe Arnaud Method and device for making a dispersion or an emulsion
US20060164912A1 (en) * 2002-10-15 2006-07-27 Christophe Arnaud Method and device for making a dispersion or an emulsion
US7458372B2 (en) 2002-10-30 2008-12-02 Pari Pharma Gmbh Inhalation therapy device
US20060102172A1 (en) * 2002-10-30 2006-05-18 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy device
US20050042170A1 (en) * 2003-02-14 2005-02-24 The Brigham And Women's Hospital, Inc. Method and device for generating mists and medical uses thereof
US20060237090A1 (en) * 2003-03-11 2006-10-26 Prolitec, S.A. Method and device for nebulisation
US8545463B2 (en) 2003-05-20 2013-10-01 Optimyst Systems Inc. Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device
US8012136B2 (en) 2003-05-20 2011-09-06 Optimyst Systems, Inc. Ophthalmic fluid delivery device and method of operation
US7883031B2 (en) 2003-05-20 2011-02-08 James F. Collins, Jr. Ophthalmic drug delivery system
US8936021B2 (en) 2003-05-20 2015-01-20 Optimyst Systems, Inc. Ophthalmic fluid delivery system
US20040256487A1 (en) * 2003-05-20 2004-12-23 Collins James F. Ophthalmic drug delivery system
US8616195B2 (en) 2003-07-18 2013-12-31 Novartis Ag Nebuliser for the production of aerosolized medication
WO2005011574A2 (en) * 2003-07-30 2005-02-10 Coifman Robert E Microporous membrane nebulizers
WO2005011574A3 (en) * 2003-07-30 2005-10-20 Robert E Coifman Microporous membrane nebulizers
US7377277B2 (en) 2003-10-27 2008-05-27 Oriel Therapeutics, Inc. Blister packages with frames and associated methods of fabricating dry powder drug containment systems
US20050109659A1 (en) * 2003-10-27 2005-05-26 Hickey Anthony J. Blister packages with frames and associated methods of fabricating dry powder drug containment systems
US20080197044A1 (en) * 2003-10-27 2008-08-21 Oriel Therapeutics, Inc. Blister packages with frames for dry powder drug containment
US7451761B2 (en) 2003-10-27 2008-11-18 Oriel Therapeutics, Inc. Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
US20050103337A1 (en) * 2003-10-27 2005-05-19 Anthony James Hickey Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
US7914517B2 (en) 2003-10-31 2011-03-29 Trudell Medical International System and method for manipulating a catheter for delivering a substance to a body cavity
US20050125002A1 (en) * 2003-10-31 2005-06-09 George Baran System and method for manipulating a catheter for delivering a substance to a body cavity
EP1694392A4 (en) * 2003-11-25 2008-05-14 Robert E Coifman Devices for measuring inspiratory airflow
WO2005051177A3 (en) * 2003-11-25 2006-03-16 Robert E Coifman Devices for measuring inspiratory airflow
EP1694392A2 (en) * 2003-11-25 2006-08-30 Robert E. Coifman Devices for measuring inspiratory airflow
US20050133024A1 (en) * 2003-11-25 2005-06-23 Coifman Robert E. Devices for measuring inspiratory airflow
US20140034051A1 (en) * 2004-02-20 2014-02-06 Pneumoflex Systems, Llc Nebulizer having horizontal venturi
US9227029B2 (en) * 2004-02-20 2016-01-05 Pneumoflex Systems, Llc Nebulizer having horizontal venturi
US20130267864A1 (en) * 2004-02-20 2013-10-10 Pneumoflex Systems, Llc Nebulizer with intra-oral vibrating mesh
US9022027B2 (en) * 2004-02-20 2015-05-05 Pneumoflex Systems, Llc Nebulizer with intra-oral vibrating mesh
US20050229927A1 (en) * 2004-04-20 2005-10-20 Aerogen, Inc. Ventilation systems and methods employing aerosol generators
WO2005102431A3 (en) * 2004-04-20 2006-06-22 Aerogen Inc Aerosol delivery apparatus for pressure assisted breathing
US7201167B2 (en) * 2004-04-20 2007-04-10 Aerogen, Inc. Method and composition for the treatment of lung surfactant deficiency or dysfunction
US7267121B2 (en) * 2004-04-20 2007-09-11 Aerogen, Inc. Aerosol delivery apparatus and method for pressure-assisted breathing systems
US7946291B2 (en) * 2004-04-20 2011-05-24 Novartis Ag Ventilation systems and methods employing aerosol generators
US7290541B2 (en) * 2004-04-20 2007-11-06 Aerogen, Inc. Aerosol delivery apparatus and method for pressure-assisted breathing systems
US20060001952A1 (en) * 2004-07-02 2006-01-05 Liekki Oy Method and device for producing optical material, and an optical waveguide
US20080308096A1 (en) * 2005-02-11 2008-12-18 Pari Pharma Gmbh Aerosol Generating Device and Inhalation Therapy Unit Provided with This Device
US9027548B2 (en) * 2005-02-11 2015-05-12 Pari Pharma Gmbh Aerosol generating device and inhalation therapy unit provided with this device
US9108211B2 (en) 2005-05-25 2015-08-18 Nektar Therapeutics Vibration systems and methods
US7712680B2 (en) * 2006-01-30 2010-05-11 Sono-Tek Corporation Ultrasonic atomizing nozzle and method
US20070176017A1 (en) * 2006-01-30 2007-08-02 Berger Harvey L Ultrasonic atomizing nozzle and method
US20070256684A1 (en) * 2006-03-10 2007-11-08 Aradigm Corporation Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations
WO2007106386A2 (en) 2006-03-10 2007-09-20 Aradgim Corporation Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations
US7958887B2 (en) 2006-03-10 2011-06-14 Aradigm Corporation Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations
US9084566B2 (en) 2006-07-07 2015-07-21 Proteus Digital Health, Inc. Smart parenteral administration system
US8371299B2 (en) 2007-04-19 2013-02-12 Respironics Respiratory Drug Delivery Ventilator aerosol delivery
US20080257337A1 (en) * 2007-04-19 2008-10-23 Denyer Jonathan S H Ventilator Aerosol Delivery
US8371290B2 (en) 2007-10-16 2013-02-12 General Electric Company Device for delivery and regulation of volatile fluids into inspiratory gas
EP2050479A3 (en) * 2007-10-16 2013-06-19 General Electric Company Apparatus, system and method for admistering an anesthetic agent for a subject breathing
US20090288659A1 (en) * 2007-10-16 2009-11-26 Heikki Haveri Apparatus, system and method for administering an anesthetic agent for a subject breathing
EP2050478A1 (en) * 2007-10-16 2009-04-22 GE Healthcare Finland Oy Device for delivery and regulation of volatile fluids into inspiratory gas
EP2050479A2 (en) * 2007-10-16 2009-04-22 General Electric Company Apparatus, system and method for admistering an anesthetic agent for a subject breathing
US9125979B2 (en) 2007-10-25 2015-09-08 Proteus Digital Health, Inc. Fluid transfer port information system
US8419638B2 (en) 2007-11-19 2013-04-16 Proteus Digital Health, Inc. Body-associated fluid transport structure evaluation devices
EP2119465A1 (en) * 2008-05-16 2009-11-18 Markos Mefar S.P.A. Nebulizer with breathing phase detecting sensor for delivering nebulized drugs to a user
US20090308945A1 (en) * 2008-06-17 2009-12-17 Jacob Loverich Liquid dispensing apparatus using a passive liquid metering method
US8348177B2 (en) 2008-06-17 2013-01-08 Davicon Corporation Liquid dispensing apparatus using a passive liquid metering method
WO2010107957A2 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010107955A2 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF BTB AND CNC HOMOLOGY 1, BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR 1 (BACH 1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) SEQUENCE LISTING
WO2010107958A1 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010107952A2 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010111490A2 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF THE THYMIC STROMAL LYMPHOPOIETIN (TSLP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010111464A1 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010111471A2 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010111468A2 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
WO2010111497A2 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF THE INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1)GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
US20120318259A1 (en) * 2010-01-12 2012-12-20 Omega Life Science Ltd. Method and apparatus for producing fine concentrated aerosol
US10857311B2 (en) 2010-01-12 2020-12-08 Omega Life Science Ltd. Method and apparatus for producing fine concentrated aerosol
US10376218B2 (en) 2010-02-01 2019-08-13 Proteus Digital Health, Inc. Data gathering system
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US9008761B2 (en) 2010-02-01 2015-04-14 Proteus Digital Health, Inc. Two-wrist data gathering system
US8332020B2 (en) 2010-02-01 2012-12-11 Proteus Digital Health, Inc. Two-wrist data gathering system
US10154923B2 (en) 2010-07-15 2018-12-18 Eyenovia, Inc. Drop generating device
US11011270B2 (en) 2010-07-15 2021-05-18 Eyenovia, Inc. Drop generating device
US8733935B2 (en) 2010-07-15 2014-05-27 Corinthian Ophthalmic, Inc. Method and system for performing remote treatment and monitoring
US11398306B2 (en) 2010-07-15 2022-07-26 Eyenovia, Inc. Ophthalmic drug delivery
US9087145B2 (en) 2010-07-15 2015-07-21 Eyenovia, Inc. Ophthalmic drug delivery
US10839960B2 (en) 2010-07-15 2020-11-17 Eyenovia, Inc. Ophthalmic drug delivery
US11839487B2 (en) 2010-07-15 2023-12-12 Eyenovia, Inc. Ophthalmic drug delivery
US8684980B2 (en) 2010-07-15 2014-04-01 Corinthian Ophthalmic, Inc. Drop generating device
US10073949B2 (en) 2010-07-15 2018-09-11 Eyenovia, Inc. Ophthalmic drug delivery
WO2012156724A2 (en) 2011-05-16 2012-11-22 The Technology Partnership Plc Separable membrane improvements
US10195633B2 (en) * 2011-05-16 2019-02-05 The Technology Partnership Plc Separable membrane improvements
US20140110500A1 (en) * 2011-05-16 2014-04-24 The Technology Partnership Plc. Separable membrane improvements
US20130108748A1 (en) * 2011-11-01 2013-05-02 Pepsico., Inc. Dispensing Nozzle with an Ultrasound Activator
US9565870B2 (en) * 2011-11-01 2017-02-14 Pepsico, Inc. Dispensing nozzle with an ultrasound activator
US10646373B2 (en) 2011-12-12 2020-05-12 Eyenovia, Inc. Ejector mechanism, ejector device, and methods of use
US10639194B2 (en) 2011-12-12 2020-05-05 Eyenovia, Inc. High modulus polymeric ejector mechanism, ejector device, and methods of use
US20140053835A1 (en) * 2012-02-16 2014-02-27 Capnia, Inc. Gas dispenser with diffusing nosepiece
US9961941B2 (en) 2012-02-22 2018-05-08 Altria Client Services Llc Electronic smoking article
US10299516B2 (en) 2012-02-22 2019-05-28 Altria Client Services Llc Electronic article
US9532597B2 (en) 2012-02-22 2017-01-03 Altria Client Services Llc Electronic smoking article
US10195634B2 (en) 2013-07-09 2019-02-05 The Technology Partnership Plc Separable membrane improvements
US11090676B2 (en) 2013-07-09 2021-08-17 The Technology Partnership Plc Separable membrane improvements
US20170021114A1 (en) * 2014-04-03 2017-01-26 Csl Behring Ag Nebulization of immunoglobulin
US11471617B2 (en) * 2014-04-03 2022-10-18 Csl Behring Ag Nebultzation of immunoglobulin
US10369301B2 (en) 2014-10-13 2019-08-06 Omega Life Science Ltd. Nebulizers and uses thereof
US10052443B2 (en) 2014-10-13 2018-08-21 Omega Life Science Ltd. Nebulizers and uses thereof
US10799652B2 (en) 2015-01-08 2020-10-13 Convexity Scientific Inc. Nebulizer device
US11819453B2 (en) 2015-01-12 2023-11-21 Novartis Ag Micro-droplet delivery device and methods
US10624781B2 (en) 2015-01-12 2020-04-21 Kedalion Therapeutics, Inc. Micro-droplet delivery device and methods
US10583038B2 (en) 2015-04-10 2020-03-10 Kedalion Therapeutics Piezoelectric dispenser with replaceable ampoule
WO2017006091A1 (en) 2015-07-03 2017-01-12 The Technology Partnership Plc Aerosol apparatus with improved separable membrane
WO2017051181A1 (en) 2015-09-22 2017-03-30 The Technology Partnership Plc Liquid nicotine formulation
WO2017064473A1 (en) 2015-10-16 2017-04-20 The Technology Partnership Plc Linear droplet generating device
AU2016344191B2 (en) * 2015-10-30 2021-07-15 Johnson & Johnson Consumer Inc. Aseptic aerosol misting device
IL258634B (en) * 2015-10-30 2022-09-01 Johnson & Johnson Consumer Inc Aseptic aerosol misting device
WO2017075318A1 (en) * 2015-10-30 2017-05-04 Johnson & Johnson Consumer Inc. Aseptic aerosol misting device
RU2728719C2 (en) * 2015-10-30 2020-07-30 Джонсон энд Джонсон Консьюмер Инк. Aseptic aerosol fogger
US11583885B2 (en) 2015-10-30 2023-02-21 Johnson & Johnson Consumer Inc. Unit dose aseptic aerosol misting device
US11571704B2 (en) 2015-10-30 2023-02-07 Johnson & Johnson Consumer Inc. Aseptic aerosol misting device
CN108348697A (en) * 2015-10-30 2018-07-31 强生消费者公司 Sterile aerosol atomising device
JP2018538030A (en) * 2015-10-30 2018-12-27 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. Aseptic aerosol mist spraying device
US11253885B2 (en) 2015-10-30 2022-02-22 Johnson & Johnson Consumer Inc. Aseptic aerosol misting device
CN108348697B (en) * 2015-10-30 2021-09-10 强生消费者公司 Sterile aerosol atomization device
US10239085B2 (en) 2015-10-30 2019-03-26 Johnson & Johnson Consumer Inc. Aseptic aerosol misting device
WO2017090011A1 (en) * 2015-11-26 2017-06-01 Ferrari Brands S.R.L. Device to deliver a substance
US10433580B2 (en) 2016-03-03 2019-10-08 Altria Client Services Llc Methods to add menthol, botanic materials, and/or non-botanic materials to a cartridge, and/or an electronic vaping device including the cartridge
US10455863B2 (en) 2016-03-03 2019-10-29 Altria Client Services Llc Cartridge for electronic vaping device
US10368580B2 (en) 2016-03-08 2019-08-06 Altria Client Services Llc Combined cartridge for electronic vaping device
US10357060B2 (en) 2016-03-11 2019-07-23 Altria Client Services Llc E-vaping device cartridge holder
US10368581B2 (en) 2016-03-11 2019-08-06 Altria Client Services Llc Multiple dispersion generator e-vaping device
US10888454B2 (en) 2017-01-20 2021-01-12 Kedalion Therapeutics, Inc. Piezoelectric fluid dispenser
US11278448B2 (en) 2017-12-08 2022-03-22 Kedalion Therapeutics, Inc. Fluid delivery alignment system
US20200129709A1 (en) * 2018-10-28 2020-04-30 Albert Ky Wearable inspiration synchronic ultrasonic nebulizer-humidifier device
US11679028B2 (en) 2019-03-06 2023-06-20 Novartis Ag Multi-dose ocular fluid delivery system
CN110721865A (en) * 2019-11-07 2020-01-24 湖南嘉业达电子有限公司 Atomizing device for atomizing essential oil
US11298472B2 (en) * 2020-04-24 2022-04-12 SOSD Health & Medical Innovations Inc. Ultrasonic nebulizer
US11925577B2 (en) 2021-04-16 2024-03-12 Bausch + Lomb Ireland Limted Hydrodynamically actuated preservative free dispensing system

Similar Documents

Publication Publication Date Title
US3812854A (en) Ultrasonic nebulizer
US5515841A (en) Inhaler
EP1332006B1 (en) Device and method for detecting and controlling liquid supply to an apparatus discharging liquid
US20210068455A1 (en) Substitute smoking device comprising multiple aerosols and passive aerosol generation
US6601581B1 (en) Method and device for ultrasound drug delivery
US5586550A (en) Apparatus and methods for the delivery of therapeutic liquids to the respiratory system
EP0794838B1 (en) Liquid dispensing apparatus and methods
US7174888B2 (en) Liquid dispensing apparatus and methods
US6539937B1 (en) Method of maximizing the mechanical displacement of a piezoelectric nebulizer apparatus
US6530370B1 (en) Nebulizer apparatus
JP4589862B2 (en) Nebulizer for inhalation
CA2130827A1 (en) Powder Nebulizer Apparatus and Method of Nebulization
EP0923957A1 (en) Liquid droplet spray device for an inhaler suitable for respiratory therapies
MY104600A (en) Electroacoustic droplet production apparatus and method
GB2345869A (en) Formation of monodisperse particles
WO2023125499A1 (en) Metered-dose atomization module, atomizer, spray assembly and use thereof
WO2023108316A1 (en) Portable precise visual atomization delivery device based on surface acoustic wave technology
CN114470433A (en) Portable accurate visual atomizing delivery equipment based on surface acoustic wave technology
WO2022219623A1 (en) Nebulizer